id	sid	tid	token	lemma	pos
bam-9817	1	1	acute	acute	ADJ
bam-9817	1	2	myelogenous	myelogenous	ADJ
bam-9817	1	3	leukemia	leukemia	NOUN
bam-9817	1	4	and	and	CCONJ
bam-9817	1	5	covid-19	covid-19	PROPN
bam-9817	1	6	infection	infection	NOUN
bam-9817	1	7	eur	eur	PROPN
bam-9817	1	8	j	j	PROPN
bam-9817	1	9	transl	transl	PROPN
bam-9817	1	10	myol	myol	ADV
bam-9817	1	11	31	31	NUM
bam-9817	1	12	(	(	PUNCT
bam-9817	1	13	3	3	NUM
bam-9817	1	14	):	):	PUNCT
bam-9817	1	15	9817	9817	NUM
bam-9817	1	16	,	,	PUNCT
bam-9817	1	17	2021	2021	NUM
bam-9817	1	18	doi	doi	NOUN
bam-9817	1	19	:	:	PUNCT
bam-9817	1	20	10.4081	10.4081	NUM
bam-9817	1	21	/	/	SYM
bam-9817	1	22	ejtm.2021.9817	ejtm.2021.9817	NOUN
bam-9817	1	23	1	1	NUM
bam-9817	1	24	isolated	isolated	ADJ
bam-9817	1	25	hyperbilirubinemia	hyperbilirubinemia	NOUN
bam-9817	1	26	as	as	ADP
bam-9817	1	27	the	the	DET
bam-9817	1	28	manifestation	manifestation	NOUN
bam-9817	1	29	of	of	ADP
bam-9817	1	30	acute	acute	ADJ
bam-9817	1	31	liver	liver	NOUN
bam-9817	1	32	failure	failure	NOUN
bam-9817	1	33	in	in	ADP
bam-9817	1	34	a	a	DET
bam-9817	1	35	patient	patient	NOUN
bam-9817	1	36	with	with	ADP
bam-9817	1	37	acute	acute	ADJ
bam-9817	1	38	myelogenous	myelogenous	ADJ
bam-9817	1	39	leukemia	leukemia	NOUN
bam-9817	1	40	and	and	CCONJ
bam-9817	1	41	covid-19	covid-19	PROPN
bam-9817	1	42	infection	infection	NOUN
bam-9817	1	43	nasrin	nasrin	NOUN
bam-9817	1	44	gholami	gholami	PROPN
bam-9817	1	45	(	(	PUNCT
bam-9817	1	46	1),vahid	1),vahid	NUM
bam-9817	1	47	sheykhzadeh	sheykhzadeh	NOUN
bam-9817	1	48	amzajerdi	amzajerdi	PROPN
bam-9817	1	49	(	(	PUNCT
bam-9817	1	50	1	1	NUM
bam-9817	1	51	)	)	PUNCT
bam-9817	1	52	,	,	PUNCT
bam-9817	1	53	rahim	rahim	PROPN
bam-9817	1	54	mehdioghli	mehdioghli	ADP
bam-9817	1	55	(	(	PUNCT
bam-9817	1	56	1	1	NUM
bam-9817	1	57	)	)	PUNCT
bam-9817	1	58	,	,	PUNCT
bam-9817	1	59	hengameh	hengameh	VERB
bam-9817	1	60	khadivi	khadivi	PROPN
bam-9817	1	61	heris	heris	ADJ
bam-9817	1	62	(	(	PUNCT
bam-9817	1	63	1	1	NUM
bam-9817	1	64	)	)	PUNCT
bam-9817	1	65	,	,	PUNCT
bam-9817	1	66	mona	mona	PROPN
bam-9817	1	67	jahandideh	jahandideh	PROPN
bam-9817	1	68	kazempour	kazempour	NOUN
bam-9817	1	69	(	(	PUNCT
bam-9817	1	70	2	2	NUM
bam-9817	1	71	)	)	PUNCT
bam-9817	1	72	(	(	PUNCT
bam-9817	1	73	1	1	X
bam-9817	1	74	)	)	PUNCT
bam-9817	1	75	hematology	hematology	NOUN
bam-9817	1	76	oncology	oncology	NOUN
bam-9817	1	77	research	research	NOUN
bam-9817	1	78	center	center	NOUN
bam-9817	1	79	,	,	PUNCT
bam-9817	1	80	tabriz	tabriz	PROPN
bam-9817	1	81	university	university	PROPN
bam-9817	1	82	of	of	ADP
bam-9817	1	83	medical	medical	ADJ
bam-9817	1	84	sciences	sciences	PROPN
bam-9817	1	85	,	,	PUNCT
bam-9817	1	86	tabriz	tabriz	NOUN
bam-9817	1	87	,	,	PUNCT
bam-9817	1	88	iran	iran	PROPN
bam-9817	1	89	(	(	PUNCT
bam-9817	1	90	2	2	NUM
bam-9817	1	91	)	)	PUNCT
bam-9817	1	92	deparment	deparment	NOUN
bam-9817	1	93	of	of	ADP
bam-9817	1	94	microbiology	microbiology	NOUN
bam-9817	1	95	,	,	PUNCT
bam-9817	1	96	faculty	faculty	NOUN
bam-9817	1	97	of	of	ADP
bam-9817	1	98	medical	medical	ADJ
bam-9817	1	99	genetic	genetic	ADJ
bam-9817	1	100	,	,	PUNCT
bam-9817	1	101	science	science	NOUN
bam-9817	1	102	and	and	CCONJ
bam-9817	1	103	research	research	PROPN
bam-9817	1	104	islamic	islamic	PROPN
bam-9817	1	105	azad	azad	PROPN
bam-9817	1	106	university	university	PROPN
bam-9817	1	107	,	,	PUNCT
bam-9817	1	108	tehran	tehran	PROPN
bam-9817	1	109	,	,	PUNCT
bam-9817	1	110	iran	iran	PROPN
bam-9817	1	111	.	.	PUNCT
bam-9817	2	1	this	this	DET
bam-9817	2	2	article	article	NOUN
bam-9817	2	3	is	be	AUX
bam-9817	2	4	distributed	distribute	VERB
bam-9817	2	5	under	under	ADP
bam-9817	2	6	the	the	DET
bam-9817	2	7	terms	term	NOUN
bam-9817	2	8	of	of	ADP
bam-9817	2	9	the	the	DET
bam-9817	2	10	creative	creative	ADJ
bam-9817	2	11	commons	common	NOUN
bam-9817	2	12	attribution	attribution	NOUN
bam-9817	2	13	noncommercial	noncommercial	ADJ
bam-9817	2	14	license	license	NOUN
bam-9817	2	15	(	(	PUNCT
bam-9817	2	16	cc	cc	NOUN
bam-9817	2	17	by	by	ADP
bam-9817	2	18	-	-	PUNCT
bam-9817	2	19	nc	nc	PROPN
bam-9817	2	20	4.0	4.0	NUM
bam-9817	2	21	)	)	PUNCT
bam-9817	2	22	which	which	PRON
bam-9817	2	23	permits	permit	VERB
bam-9817	2	24	any	any	DET
bam-9817	2	25	noncommercial	noncommercial	ADJ
bam-9817	2	26	use	use	NOUN
bam-9817	2	27	,	,	PUNCT
bam-9817	2	28	distribution	distribution	NOUN
bam-9817	2	29	,	,	PUNCT
bam-9817	2	30	and	and	CCONJ
bam-9817	2	31	reproduction	reproduction	NOUN
bam-9817	2	32	in	in	ADP
bam-9817	2	33	any	any	DET
bam-9817	2	34	medium	medium	NOUN
bam-9817	2	35	,	,	PUNCT
bam-9817	2	36	provided	provide	VERB
bam-9817	2	37	the	the	DET
bam-9817	2	38	original	original	ADJ
bam-9817	2	39	author(s	author(s	NOUN
bam-9817	2	40	)	)	PUNCT
bam-9817	2	41	and	and	CCONJ
bam-9817	2	42	source	source	NOUN
bam-9817	2	43	are	be	AUX
bam-9817	2	44	credited	credit	VERB
bam-9817	2	45	.	.	PUNCT
bam-9817	3	1	abstract	abstract	ADJ
bam-9817	3	2	acute	acute	ADJ
bam-9817	3	3	liver	liver	NOUN
bam-9817	3	4	failure	failure	NOUN
bam-9817	3	5	is	be	AUX
bam-9817	3	6	a	a	DET
bam-9817	3	7	rare	rare	ADJ
bam-9817	3	8	but	but	CCONJ
bam-9817	3	9	catastrophic	catastrophic	ADJ
bam-9817	3	10	syndrome	syndrome	NOUN
bam-9817	3	11	.	.	PUNCT
bam-9817	4	1	liver	liver	NOUN
bam-9817	4	2	function	function	NOUN
bam-9817	4	3	tests	test	NOUN
bam-9817	4	4	usually	usually	ADV
bam-9817	4	5	reveal	reveal	VERB
bam-9817	4	6	cholestatic	cholestatic	ADJ
bam-9817	4	7	or	or	CCONJ
bam-9817	4	8	hepatocellular	hepatocellular	ADJ
bam-9817	4	9	pattern	pattern	NOUN
bam-9817	4	10	,	,	PUNCT
bam-9817	4	11	but	but	CCONJ
bam-9817	4	12	in	in	ADP
bam-9817	4	13	this	this	DET
bam-9817	4	14	case	case	NOUN
bam-9817	4	15	,	,	PUNCT
bam-9817	4	16	we	we	PRON
bam-9817	4	17	report	report	VERB
bam-9817	4	18	a	a	DET
bam-9817	4	19	previously	previously	ADV
bam-9817	4	20	undescribed	undescribed	ADJ
bam-9817	4	21	manifestation	manifestation	NOUN
bam-9817	4	22	of	of	ADP
bam-9817	4	23	this	this	DET
bam-9817	4	24	condition	condition	NOUN
bam-9817	4	25	as	as	ADP
bam-9817	4	26	isolated	isolated	ADJ
bam-9817	4	27	hyperbilirubinemia	hyperbilirubinemia	NOUN
bam-9817	4	28	.	.	PUNCT
bam-9817	5	1	our	our	PRON
bam-9817	5	2	patient	patient	NOUN
bam-9817	5	3	was	be	AUX
bam-9817	5	4	a	a	DET
bam-9817	5	5	50	50	NUM
bam-9817	5	6	years	year	NOUN
bam-9817	5	7	old	old	ADJ
bam-9817	5	8	male	male	NOUN
bam-9817	5	9	who	who	PRON
bam-9817	5	10	was	be	AUX
bam-9817	5	11	diagnosed	diagnose	VERB
bam-9817	5	12	with	with	ADP
bam-9817	5	13	acute	acute	ADJ
bam-9817	5	14	myelogenous	myelogenous	ADJ
bam-9817	5	15	leukemia	leukemia	NOUN
bam-9817	5	16	(	(	PUNCT
bam-9817	5	17	aml(m4	aml(m4	NOUN
bam-9817	5	18	)	)	PUNCT
bam-9817	5	19	)	)	PUNCT
bam-9817	5	20	.	.	PUNCT
bam-9817	6	1	the	the	DET
bam-9817	6	2	patient	patient	NOUN
bam-9817	6	3	had	have	VERB
bam-9817	6	4	no	no	DET
bam-9817	6	5	history	history	NOUN
bam-9817	6	6	of	of	ADP
bam-9817	6	7	liver	liver	NOUN
bam-9817	6	8	disease	disease	NOUN
bam-9817	6	9	and	and	CCONJ
bam-9817	6	10	had	have	VERB
bam-9817	6	11	normal	normal	ADJ
bam-9817	6	12	liver	liver	NOUN
bam-9817	6	13	function	function	NOUN
bam-9817	6	14	tests	test	NOUN
bam-9817	6	15	at	at	ADP
bam-9817	6	16	the	the	DET
bam-9817	6	17	time	time	NOUN
bam-9817	6	18	of	of	ADP
bam-9817	6	19	admission	admission	NOUN
bam-9817	6	20	.	.	PUNCT
bam-9817	7	1	after	after	ADP
bam-9817	7	2	chemotherapy	chemotherapy	NOUN
bam-9817	7	3	treatment	treatment	NOUN
bam-9817	7	4	,	,	PUNCT
bam-9817	7	5	the	the	DET
bam-9817	7	6	patient	patient	NOUN
bam-9817	7	7	developed	develop	VERB
bam-9817	7	8	signs	sign	NOUN
bam-9817	7	9	of	of	ADP
bam-9817	7	10	acute	acute	ADJ
bam-9817	7	11	liver	liver	NOUN
bam-9817	7	12	failure	failure	NOUN
bam-9817	7	13	and	and	CCONJ
bam-9817	7	14	had	have	VERB
bam-9817	7	15	a	a	DET
bam-9817	7	16	rapid	rapid	ADJ
bam-9817	7	17	demise	demise	NOUN
bam-9817	7	18	.	.	PUNCT
bam-9817	8	1	after	after	ADP
bam-9817	8	2	further	further	ADJ
bam-9817	8	3	investigations	investigation	NOUN
bam-9817	8	4	,	,	PUNCT
bam-9817	8	5	we	we	PRON
bam-9817	8	6	found	find	VERB
bam-9817	8	7	two	two	NUM
bam-9817	8	8	possible	possible	ADJ
bam-9817	8	9	causes	cause	NOUN
bam-9817	8	10	.	.	PUNCT
bam-9817	9	1	firstly	firstly	ADV
bam-9817	9	2	,	,	PUNCT
bam-9817	9	3	liver	liver	NOUN
bam-9817	9	4	involvement	involvement	NOUN
bam-9817	9	5	of	of	ADP
bam-9817	9	6	acute	acute	ADJ
bam-9817	9	7	myelogenous	myelogenous	ADJ
bam-9817	9	8	leukemia	leukemia	NOUN
bam-9817	9	9	(	(	PUNCT
bam-9817	9	10	aml	aml	PROPN
bam-9817	9	11	)	)	PUNCT
bam-9817	9	12	which	which	PRON
bam-9817	9	13	after	after	ADP
bam-9817	9	14	induction	induction	NOUN
bam-9817	9	15	chemotherapy	chemotherapy	NOUN
bam-9817	9	16	is	be	AUX
bam-9817	9	17	a	a	DET
bam-9817	9	18	rare	rare	ADJ
bam-9817	9	19	condition	condition	NOUN
bam-9817	9	20	and	and	CCONJ
bam-9817	9	21	has	have	VERB
bam-9817	9	22	high	high	ADJ
bam-9817	9	23	mortality	mortality	NOUN
bam-9817	9	24	rates	rate	NOUN
bam-9817	9	25	despite	despite	SCONJ
bam-9817	9	26	treatment	treatment	NOUN
bam-9817	9	27	.	.	PUNCT
bam-9817	10	1	secondly	secondly	ADV
bam-9817	10	2	,	,	PUNCT
bam-9817	10	3	acute	acute	ADJ
bam-9817	10	4	liver	liver	NOUN
bam-9817	10	5	injury	injury	NOUN
bam-9817	10	6	due	due	ADP
bam-9817	10	7	to	to	ADP
bam-9817	10	8	covid-19	covid-19	PROPN
bam-9817	10	9	infection	infection	NOUN
bam-9817	10	10	.	.	PUNCT
bam-9817	11	1	key	key	ADJ
bam-9817	11	2	words	word	NOUN
bam-9817	11	3	:	:	PUNCT
bam-9817	11	4	isolated	isolated	ADJ
bam-9817	11	5	hyperbilirubinemia	hyperbilirubinemia	NOUN
bam-9817	11	6	;	;	PUNCT
bam-9817	11	7	acute	acute	ADJ
bam-9817	11	8	myelogenous	myelogenous	ADJ
bam-9817	11	9	leukemia	leukemia	NOUN
bam-9817	11	10	;	;	PUNCT
bam-9817	11	11	acute	acute	ADJ
bam-9817	11	12	liver	liver	NOUN
bam-9817	11	13	failure	failure	NOUN
bam-9817	11	14	;	;	PUNCT
bam-9817	11	15	covid-19	covid-19	PROPN
bam-9817	11	16	.	.	PUNCT
bam-9817	12	1	eur	eur	PROPN
bam-9817	12	2	j	j	PROPN
bam-9817	12	3	transl	transl	PROPN
bam-9817	12	4	myol	myol	ADV
bam-9817	12	5	31	31	NUM
bam-9817	12	6	(	(	PUNCT
bam-9817	12	7	3	3	NUM
bam-9817	12	8	):	):	PUNCT
bam-9817	12	9	9817	9817	NUM
bam-9817	12	10	,	,	PUNCT
bam-9817	12	11	2021	2021	NUM
bam-9817	12	12	doi	doi	NOUN
bam-9817	12	13	:	:	PUNCT
bam-9817	12	14	10.4081	10.4081	NUM
bam-9817	12	15	/	/	SYM
bam-9817	12	16	ejtm.2021.9817	ejtm.2021.9817	NOUN
bam-9817	12	17	acute	acute	NOUN
bam-9817	12	18	liver	liver	NOUN
bam-9817	12	19	failure	failure	NOUN
bam-9817	12	20	usually	usually	ADV
bam-9817	12	21	manifests	manifest	VERB
bam-9817	12	22	itself	itself	PRON
bam-9817	12	23	as	as	ADP
bam-9817	12	24	clinical	clinical	ADJ
bam-9817	12	25	signs	sign	NOUN
bam-9817	12	26	and	and	CCONJ
bam-9817	12	27	symptoms	symptom	NOUN
bam-9817	12	28	or	or	CCONJ
bam-9817	12	29	abnormal	abnormal	ADJ
bam-9817	12	30	liver	liver	NOUN
bam-9817	12	31	function	function	NOUN
bam-9817	12	32	tests	test	NOUN
bam-9817	12	33	with	with	ADP
bam-9817	12	34	a	a	DET
bam-9817	12	35	hepatocellular	hepatocellular	NOUN
bam-9817	12	36	or	or	CCONJ
bam-9817	12	37	a	a	DET
bam-9817	12	38	cholestatic	cholestatic	ADJ
bam-9817	12	39	pattern.1	pattern.1	NOUN
bam-9817	12	40	isolated	isolate	VERB
bam-9817	12	41	hyperbilirubinemia	hyperbilirubinemia	NOUN
bam-9817	12	42	is	be	AUX
bam-9817	12	43	a	a	DET
bam-9817	12	44	very	very	ADV
bam-9817	12	45	rare	rare	ADJ
bam-9817	12	46	manifestation	manifestation	NOUN
bam-9817	12	47	to	to	ADP
bam-9817	12	48	the	the	DET
bam-9817	12	49	best	good	ADJ
bam-9817	12	50	of	of	ADP
bam-9817	12	51	our	our	PRON
bam-9817	12	52	knowledge	knowledge	NOUN
bam-9817	12	53	.	.	PUNCT
bam-9817	13	1	moreover	moreover	ADV
bam-9817	13	2	,	,	PUNCT
bam-9817	13	3	liver	liver	NOUN
bam-9817	13	4	involvement	involvement	NOUN
bam-9817	13	5	with	with	ADP
bam-9817	13	6	acute	acute	ADJ
bam-9817	13	7	myelogenous	myelogenous	ADJ
bam-9817	13	8	leukemia	leukemia	NOUN
bam-9817	13	9	(	(	PUNCT
bam-9817	13	10	aml	aml	PROPN
bam-9817	13	11	)	)	PUNCT
bam-9817	13	12	has	have	AUX
bam-9817	13	13	rarely	rarely	ADV
bam-9817	13	14	been	be	AUX
bam-9817	13	15	reported	report	VERB
bam-9817	13	16	.	.	PUNCT
bam-9817	14	1	most	most	ADJ
bam-9817	14	2	reported	report	VERB
bam-9817	14	3	cases	case	NOUN
bam-9817	14	4	of	of	ADP
bam-9817	14	5	aml	aml	NOUN
bam-9817	14	6	with	with	ADP
bam-9817	14	7	liver	liver	NOUN
bam-9817	14	8	involvement	involvement	NOUN
bam-9817	14	9	had	have	VERB
bam-9817	14	10	an	an	DET
bam-9817	14	11	exacerbating	exacerbate	VERB
bam-9817	14	12	disease	disease	NOUN
bam-9817	14	13	course	course	NOUN
bam-9817	14	14	with	with	ADP
bam-9817	14	15	a	a	DET
bam-9817	14	16	very	very	ADV
bam-9817	14	17	poor	poor	ADJ
bam-9817	14	18	outcome.2,3	outcome.2,3	PROPN
bam-9817	14	19	furthermore	furthermore	ADV
bam-9817	14	20	,	,	PUNCT
bam-9817	14	21	it	it	PRON
bam-9817	14	22	is	be	AUX
bam-9817	14	23	known	know	VERB
bam-9817	14	24	that	that	SCONJ
bam-9817	14	25	viral	viral	ADJ
bam-9817	14	26	infections	infection	NOUN
bam-9817	14	27	play	play	VERB
bam-9817	14	28	a	a	DET
bam-9817	14	29	major	major	ADJ
bam-9817	14	30	role	role	NOUN
bam-9817	14	31	in	in	ADP
bam-9817	14	32	causing	cause	VERB
bam-9817	14	33	acute	acute	ADJ
bam-9817	14	34	liver	liver	NOUN
bam-9817	14	35	injury	injury	NOUN
bam-9817	14	36	,	,	PUNCT
bam-9817	14	37	especially	especially	ADV
bam-9817	14	38	in	in	ADP
bam-9817	14	39	developing	develop	VERB
bam-9817	14	40	countries.1	countries.1	NOUN
bam-9817	14	41	we	we	PRON
bam-9817	14	42	could	could	AUX
bam-9817	14	43	not	not	PART
bam-9817	14	44	find	find	VERB
bam-9817	14	45	any	any	DET
bam-9817	14	46	trace	trace	NOUN
bam-9817	14	47	of	of	ADP
bam-9817	14	48	hepatotropic	hepatotropic	NOUN
bam-9817	14	49	viruses	virus	NOUN
bam-9817	14	50	in	in	ADP
bam-9817	14	51	this	this	DET
bam-9817	14	52	case	case	NOUN
bam-9817	14	53	,	,	PUNCT
bam-9817	14	54	but	but	CCONJ
bam-9817	14	55	we	we	PRON
bam-9817	14	56	found	find	VERB
bam-9817	14	57	a	a	DET
bam-9817	14	58	covid-19	covid-19	PROPN
bam-9817	14	59	infection	infection	NOUN
bam-9817	14	60	which	which	PRON
bam-9817	14	61	could	could	AUX
bam-9817	14	62	be	be	AUX
bam-9817	14	63	a	a	DET
bam-9817	14	64	risk	risk	NOUN
bam-9817	14	65	factor	factor	NOUN
bam-9817	14	66	or	or	CCONJ
bam-9817	14	67	a	a	DET
bam-9817	14	68	comorbidity	comorbidity	NOUN
bam-9817	14	69	of	of	ADP
bam-9817	14	70	acute	acute	ADJ
bam-9817	14	71	liver	liver	NOUN
bam-9817	14	72	failure	failure	NOUN
bam-9817	14	73	.	.	PUNCT
bam-9817	15	1	case	case	NOUN
bam-9817	15	2	presentation	presentation	NOUN
bam-9817	15	3	a	a	DET
bam-9817	15	4	50	50	NUM
bam-9817	15	5	years	year	NOUN
bam-9817	15	6	old	old	ADJ
bam-9817	15	7	addicted	addict	VERB
bam-9817	15	8	(	(	PUNCT
bam-9817	15	9	to	to	PART
bam-9817	15	10	edible	edible	ADJ
bam-9817	15	11	opium	opium	NOUN
bam-9817	15	12	)	)	PUNCT
bam-9817	15	13	male	male	NOUN
bam-9817	15	14	with	with	ADP
bam-9817	15	15	no	no	DET
bam-9817	15	16	significant	significant	ADJ
bam-9817	15	17	past	past	NOUN
bam-9817	15	18	medical	medical	ADJ
bam-9817	15	19	history	history	NOUN
bam-9817	15	20	was	be	AUX
bam-9817	15	21	referred	refer	VERB
bam-9817	15	22	to	to	ADP
bam-9817	15	23	our	our	PRON
bam-9817	15	24	hematology	hematology	NOUN
bam-9817	15	25	department	department	NOUN
bam-9817	15	26	for	for	ADP
bam-9817	15	27	investigations	investigation	NOUN
bam-9817	15	28	.	.	PUNCT
bam-9817	16	1	the	the	DET
bam-9817	16	2	patient	patient	NOUN
bam-9817	16	3	complained	complain	VERB
bam-9817	16	4	about	about	ADP
bam-9817	16	5	a	a	DET
bam-9817	16	6	2	2	NUM
bam-9817	16	7	-	-	PUNCT
bam-9817	16	8	months	month	NOUN
bam-9817	16	9	history	history	NOUN
bam-9817	16	10	of	of	ADP
bam-9817	16	11	loss	loss	NOUN
bam-9817	16	12	of	of	ADP
bam-9817	16	13	appetite	appetite	NOUN
bam-9817	16	14	and	and	CCONJ
bam-9817	16	15	2	2	NUM
bam-9817	16	16	-	-	PUNCT
bam-9817	16	17	weeks	week	NOUN
bam-9817	16	18	of	of	ADP
bam-9817	16	19	generalized	generalized	ADJ
bam-9817	16	20	ecchymotic	ecchymotic	ADJ
bam-9817	16	21	and	and	CCONJ
bam-9817	16	22	petechial	petechial	ADJ
bam-9817	16	23	skin	skin	NOUN
bam-9817	16	24	lesions	lesion	NOUN
bam-9817	16	25	mostly	mostly	ADV
bam-9817	16	26	on	on	ADP
bam-9817	16	27	lower	low	ADJ
bam-9817	16	28	limbs	limb	NOUN
bam-9817	16	29	.	.	PUNCT
bam-9817	17	1	laboratory	laboratory	NOUN
bam-9817	17	2	analysis	analysis	NOUN
bam-9817	17	3	showed	show	VERB
bam-9817	17	4	leukocytosis	leukocytosis	NOUN
bam-9817	17	5	(	(	PUNCT
bam-9817	17	6	wbc	wbc	NOUN
bam-9817	17	7	:	:	PUNCT
bam-9817	17	8	50	50	NUM
bam-9817	17	9	000	000	NUM
bam-9817	17	10	/	/	SYM
bam-9817	17	11	ml	ml	VERB
bam-9817	17	12	)	)	PUNCT
bam-9817	17	13	with	with	ADP
bam-9817	17	14	thrombocytopenia	thrombocytopenia	PROPN
bam-9817	17	15	(	(	PUNCT
bam-9817	17	16	plt	plt	NOUN
bam-9817	17	17	:	:	PUNCT
bam-9817	17	18	12000	12000	NUM
bam-9817	17	19	/	/	SYM
bam-9817	17	20	ml	ml	NOUN
bam-9817	17	21	)	)	PUNCT
bam-9817	17	22	and	and	CCONJ
bam-9817	17	23	anemia	anemia	NOUN
bam-9817	17	24	(	(	PUNCT
bam-9817	17	25	hb	hb	X
bam-9817	17	26	:	:	PUNCT
bam-9817	17	27	11	11	NUM
bam-9817	17	28	g	g	PROPN
bam-9817	17	29	/	/	SYM
bam-9817	17	30	dl	dl	NOUN
bam-9817	17	31	)	)	PUNCT
bam-9817	17	32	.	.	PUNCT
bam-9817	18	1	the	the	DET
bam-9817	18	2	patient	patient	NOUN
bam-9817	18	3	was	be	AUX
bam-9817	18	4	admitted	admit	VERB
bam-9817	18	5	to	to	ADP
bam-9817	18	6	the	the	DET
bam-9817	18	7	hematology	hematology	NOUN
bam-9817	18	8	ward	ward	NOUN
bam-9817	18	9	with	with	ADP
bam-9817	18	10	a	a	DET
bam-9817	18	11	possible	possible	ADJ
bam-9817	18	12	diagnosis	diagnosis	NOUN
bam-9817	18	13	of	of	ADP
bam-9817	18	14	leukemia	leukemia	NOUN
bam-9817	18	15	.	.	PUNCT
bam-9817	19	1	after	after	ADP
bam-9817	19	2	admission	admission	NOUN
bam-9817	19	3	,	,	PUNCT
bam-9817	19	4	the	the	DET
bam-9817	19	5	patient	patient	ADJ
bam-9817	19	6	underwent	underwent	NOUN
bam-9817	19	7	bone	bone	NOUN
bam-9817	19	8	marrow	marrow	NOUN
bam-9817	19	9	biopsy	biopsy	NOUN
bam-9817	19	10	and	and	CCONJ
bam-9817	19	11	bone	bone	NOUN
bam-9817	19	12	marrow	marrow	NOUN
bam-9817	19	13	aspiration	aspiration	NOUN
bam-9817	19	14	(	(	PUNCT
bam-9817	19	15	figure	figure	NOUN
bam-9817	19	16	1	1	NUM
bam-9817	19	17	,	,	PUNCT
bam-9817	19	18	upper	upper	ADJ
bam-9817	19	19	left	left	ADJ
bam-9817	19	20	panel	panel	NOUN
bam-9817	19	21	)	)	PUNCT
bam-9817	19	22	which	which	PRON
bam-9817	19	23	confirmed	confirm	VERB
bam-9817	19	24	acute	acute	ADJ
bam-9817	19	25	myelogenous	myelogenous	ADJ
bam-9817	19	26	leukemia	leukemia	NOUN
bam-9817	19	27	(	(	PUNCT
bam-9817	19	28	m4	m4	PROPN
bam-9817	19	29	,	,	PUNCT
bam-9817	19	30	aml	aml	PROPN
bam-9817	19	31	)	)	PUNCT
bam-9817	19	32	.	.	PUNCT
bam-9817	20	1	on	on	ADP
bam-9817	20	2	the	the	DET
bam-9817	20	3	3rd	3rd	ADJ
bam-9817	20	4	day	day	NOUN
bam-9817	20	5	of	of	ADP
bam-9817	20	6	admission	admission	NOUN
bam-9817	20	7	,	,	PUNCT
bam-9817	20	8	the	the	DET
bam-9817	20	9	induction	induction	NOUN
bam-9817	20	10	chemotherapy	chemotherapy	NOUN
bam-9817	20	11	with	with	ADP
bam-9817	20	12	standard	standard	ADJ
bam-9817	20	13	7	7	NUM
bam-9817	20	14	+	+	SYM
bam-9817	20	15	3	3	NUM
bam-9817	20	16	regimen	regiman	NOUN
bam-9817	20	17	(	(	PUNCT
bam-9817	20	18	7	7	NUM
bam-9817	20	19	days	day	NOUN
bam-9817	20	20	cytarabine	cytarabine	NOUN
bam-9817	20	21	100	100	NUM
bam-9817	20	22	mg	mg	PROPN
bam-9817	20	23	/	/	SYM
bam-9817	20	24	m²	m²	PROPN
bam-9817	20	25	,	,	PUNCT
bam-9817	20	26	3	3	NUM
bam-9817	20	27	days	day	NOUN
bam-9817	20	28	idarubicin	idarubicin	VERB
bam-9817	20	29	12	12	NUM
bam-9817	20	30	mg	mg	PROPN
bam-9817	20	31	/	/	SYM
bam-9817	20	32	m²	m²	PROPN
bam-9817	20	33	)	)	PUNCT
bam-9817	20	34	was	be	AUX
bam-9817	20	35	started	start	VERB
bam-9817	20	36	.	.	PUNCT
bam-9817	21	1	wbc	wbc	PROPN
bam-9817	21	2	count	count	NOUN
bam-9817	21	3	decreased	decrease	VERB
bam-9817	21	4	rapidly	rapidly	ADV
bam-9817	21	5	,	,	PUNCT
bam-9817	21	6	and	and	CCONJ
bam-9817	21	7	on	on	ADP
bam-9817	21	8	the	the	DET
bam-9817	21	9	6th	6th	ADJ
bam-9817	21	10	day	day	NOUN
bam-9817	21	11	after	after	ADP
bam-9817	21	12	admission	admission	NOUN
bam-9817	21	13	,	,	PUNCT
bam-9817	21	14	the	the	DET
bam-9817	21	15	patient	patient	NOUN
bam-9817	21	16	went	go	VERB
bam-9817	21	17	in	in	ADP
bam-9817	21	18	a	a	DET
bam-9817	21	19	deep	deep	ADJ
bam-9817	21	20	neutropenic	neutropenic	ADJ
bam-9817	21	21	state	state	NOUN
bam-9817	21	22	with	with	ADP
bam-9817	21	23	an	an	DET
bam-9817	21	24	average	average	ADJ
bam-9817	21	25	absolute	absolute	ADJ
bam-9817	21	26	neutrophil	neutrophil	ADJ
bam-9817	21	27	count	count	NOUN
bam-9817	21	28	of	of	ADP
bam-9817	21	29	50	50	NUM
bam-9817	21	30	/ml	/ml	PUNCT
bam-9817	21	31	.	.	PUNCT
bam-9817	22	1	the	the	DET
bam-9817	22	2	bone	bone	NOUN
bam-9817	22	3	marrow	marrow	NOUN
bam-9817	22	4	continued	continue	VERB
bam-9817	22	5	to	to	PART
bam-9817	22	6	be	be	AUX
bam-9817	22	7	suppressed	suppress	VERB
bam-9817	22	8	throughout	throughout	ADP
bam-9817	22	9	the	the	DET
bam-9817	22	10	disease	disease	NOUN
bam-9817	22	11	course	course	NOUN
bam-9817	22	12	.	.	PUNCT
bam-9817	23	1	platelet	platelet	NOUN
bam-9817	23	2	count	count	NOUN
bam-9817	23	3	(	(	PUNCT
bam-9817	23	4	10000	10000	NUM
bam-9817	23	5	/	/	SYM
bam-9817	23	6	ml	ml	PROPN
bam-9817	23	7	on	on	ADP
bam-9817	23	8	average	average	ADJ
bam-9817	23	9	)	)	PUNCT
bam-9817	23	10	and	and	CCONJ
bam-9817	23	11	hemoglobin	hemoglobin	NOUN
bam-9817	23	12	levels	level	NOUN
bam-9817	23	13	(	(	PUNCT
bam-9817	23	14	6	6	NUM
bam-9817	23	15	-	-	SYM
bam-9817	23	16	7	7	NUM
bam-9817	23	17	g	g	NOUN
bam-9817	23	18	/	/	SYM
bam-9817	23	19	dl	dl	PROPN
bam-9817	23	20	on	on	ADP
bam-9817	23	21	average	average	ADJ
bam-9817	23	22	)	)	PUNCT
bam-9817	23	23	,	,	PUNCT
bam-9817	23	24	remained	remain	VERB
bam-9817	23	25	low	low	ADJ
bam-9817	23	26	although	although	SCONJ
bam-9817	23	27	the	the	DET
bam-9817	23	28	patient	patient	NOUN
bam-9817	23	29	was	be	AUX
bam-9817	23	30	receiving	receive	VERB
bam-9817	23	31	10	10	NUM
bam-9817	23	32	units	unit	NOUN
bam-9817	23	33	of	of	ADP
bam-9817	23	34	platelets	platelet	NOUN
bam-9817	23	35	and	and	CCONJ
bam-9817	23	36	2	2	NUM
bam-9817	23	37	units	unit	NOUN
bam-9817	23	38	of	of	ADP
bam-9817	23	39	packed	packed	ADJ
bam-9817	23	40	-	-	PUNCT
bam-9817	23	41	cells	cell	NOUN
bam-9817	23	42	daily	daily	ADV
bam-9817	23	43	.	.	PUNCT
bam-9817	24	1	on	on	ADP
bam-9817	24	2	the	the	DET
bam-9817	24	3	12th	12th	ADJ
bam-9817	24	4	day	day	NOUN
bam-9817	24	5	after	after	ADP
bam-9817	24	6	admission	admission	NOUN
bam-9817	24	7	,	,	PUNCT
bam-9817	24	8	the	the	DET
bam-9817	24	9	patient	patient	NOUN
bam-9817	24	10	developed	develop	VERB
bam-9817	24	11	mild	mild	ADJ
bam-9817	24	12	jaundice	jaundice	NOUN
bam-9817	24	13	,	,	PUNCT
bam-9817	24	14	which	which	PRON
bam-9817	24	15	was	be	AUX
bam-9817	24	16	visibly	visibly	ADV
bam-9817	24	17	progressive	progressive	ADJ
bam-9817	24	18	,	,	PUNCT
bam-9817	24	19	and	and	CCONJ
bam-9817	24	20	subjectively	subjectively	ADV
bam-9817	24	21	the	the	DET
bam-9817	24	22	patient	patient	NOUN
bam-9817	24	23	became	become	VERB
bam-9817	24	24	more	more	ADV
bam-9817	24	25	icteric	icteric	ADJ
bam-9817	24	26	every	every	DET
bam-9817	24	27	day	day	NOUN
bam-9817	24	28	.	.	PUNCT
bam-9817	25	1	in	in	ADP
bam-9817	25	2	addition	addition	NOUN
bam-9817	25	3	,	,	PUNCT
bam-9817	25	4	the	the	DET
bam-9817	25	5	bilirubin	bilirubin	NOUN
bam-9817	25	6	levels	level	NOUN
bam-9817	25	7	,	,	PUNCT
bam-9817	25	8	especially	especially	ADV
bam-9817	25	9	conjugated	conjugate	VERB
bam-9817	25	10	bilirubin	bilirubin	NOUN
bam-9817	25	11	started	start	VERB
bam-9817	25	12	to	to	PART
bam-9817	25	13	rise	rise	VERB
bam-9817	25	14	but	but	CCONJ
bam-9817	25	15	curiously	curiously	ADV
bam-9817	25	16	ast	ast	VERB
bam-9817	25	17	and	and	CCONJ
bam-9817	25	18	alt	alt	PROPN
bam-9817	25	19	levels	level	NOUN
bam-9817	25	20	remained	remain	VERB
bam-9817	25	21	normal	normal	ADJ
bam-9817	25	22	.	.	PUNCT
bam-9817	26	1	albumin	albumin	ADJ
bam-9817	26	2	levels	level	NOUN
bam-9817	26	3	dropped	drop	VERB
bam-9817	26	4	and	and	CCONJ
bam-9817	26	5	the	the	DET
bam-9817	26	6	patient	patient	NOUN
bam-9817	26	7	slowly	slowly	ADV
bam-9817	26	8	developed	develop	VERB
bam-9817	26	9	progressive	progressive	ADJ
bam-9817	26	10	pitting	pit	VERB
bam-9817	26	11	edema	edema	NOUN
bam-9817	26	12	which	which	PRON
bam-9817	26	13	later	later	ADV
bam-9817	26	14	transformed	transform	VERB
bam-9817	26	15	into	into	ADP
bam-9817	26	16	severe	severe	ADJ
bam-9817	26	17	anasarca	anasarca	NOUN
bam-9817	26	18	edema	edema	NOUN
bam-9817	26	19	.	.	PUNCT
bam-9817	27	1	the	the	DET
bam-9817	27	2	acute	acute	ADJ
bam-9817	27	3	myelogenous	myelogenous	ADJ
bam-9817	27	4	leukemia	leukemia	NOUN
bam-9817	27	5	and	and	CCONJ
bam-9817	27	6	covid-19	covid-19	PROPN
bam-9817	27	7	infection	infection	NOUN
bam-9817	27	8	eur	eur	PROPN
bam-9817	27	9	j	j	PROPN
bam-9817	27	10	transl	transl	PROPN
bam-9817	27	11	myol	myol	ADV
bam-9817	27	12	31	31	NUM
bam-9817	27	13	(	(	PUNCT
bam-9817	27	14	3	3	NUM
bam-9817	27	15	):	):	PUNCT
bam-9817	27	16	9817	9817	NUM
bam-9817	27	17	,	,	PUNCT
bam-9817	27	18	2021	2021	NUM
bam-9817	27	19	doi	doi	NOUN
bam-9817	27	20	:	:	PUNCT
bam-9817	27	21	10.4081	10.4081	NUM
bam-9817	27	22	/	/	SYM
bam-9817	27	23	ejtm.2021.9817	ejtm.2021.9817	PROPN
bam-9817	27	24	2	2	NUM
bam-9817	27	25	administration	administration	NOUN
bam-9817	27	26	of	of	ADP
bam-9817	27	27	nac	nac	PROPN
bam-9817	27	28	was	be	AUX
bam-9817	27	29	started	start	VERB
bam-9817	27	30	.	.	PUNCT
bam-9817	28	1	on	on	ADP
bam-9817	28	2	the	the	DET
bam-9817	28	3	16th	16th	ADJ
bam-9817	28	4	day	day	NOUN
bam-9817	28	5	after	after	ADP
bam-9817	28	6	admission	admission	NOUN
bam-9817	28	7	,	,	PUNCT
bam-9817	28	8	the	the	DET
bam-9817	28	9	patient	patient	NOUN
bam-9817	28	10	developed	develop	VERB
bam-9817	28	11	signs	sign	NOUN
bam-9817	28	12	of	of	ADP
bam-9817	28	13	hepatic	hepatic	ADJ
bam-9817	28	14	encephalopathy	encephalopathy	NOUN
bam-9817	28	15	including	include	VERB
bam-9817	28	16	asterixis	asterixis	ADJ
bam-9817	28	17	and	and	CCONJ
bam-9817	28	18	altered	alter	VERB
bam-9817	28	19	sleep	sleep	NOUN
bam-9817	28	20	pattern	pattern	NOUN
bam-9817	28	21	so	so	ADV
bam-9817	28	22	lactulose	lactulose	NOUN
bam-9817	28	23	30	30	NUM
bam-9817	28	24	cc	cc	NOUN
bam-9817	28	25	tds	tds	PROPN
bam-9817	28	26	was	be	AUX
bam-9817	28	27	prescribed	prescribe	VERB
bam-9817	28	28	.	.	PUNCT
bam-9817	29	1	in	in	ADP
bam-9817	29	2	addition	addition	NOUN
bam-9817	29	3	,	,	PUNCT
bam-9817	29	4	prothrombin	prothrombin	ADJ
bam-9817	29	5	time	time	NOUN
bam-9817	29	6	and	and	CCONJ
bam-9817	29	7	inr	inr	PROPN
bam-9817	29	8	began	begin	VERB
bam-9817	29	9	to	to	PART
bam-9817	29	10	elevate	elevate	VERB
bam-9817	29	11	(	(	PUNCT
bam-9817	29	12	figure	figure	NOUN
bam-9817	29	13	1	1	NUM
bam-9817	29	14	,	,	PUNCT
bam-9817	29	15	upper	upper	ADJ
bam-9817	29	16	right	right	ADJ
bam-9817	29	17	panel	panel	NOUN
bam-9817	29	18	)	)	PUNCT
bam-9817	29	19	,	,	PUNCT
bam-9817	29	20	subsequently	subsequently	ADV
bam-9817	29	21	,	,	PUNCT
bam-9817	29	22	the	the	DET
bam-9817	29	23	infusion	infusion	NOUN
bam-9817	29	24	of	of	ADP
bam-9817	29	25	2	2	NUM
bam-9817	29	26	units	unit	NOUN
bam-9817	29	27	of	of	ADP
bam-9817	29	28	fresh	fresh	ADJ
bam-9817	29	29	frozen	frozen	ADJ
bam-9817	29	30	plasma	plasma	NOUN
bam-9817	29	31	every	every	DET
bam-9817	29	32	12	12	NUM
bam-9817	29	33	hours	hour	NOUN
bam-9817	29	34	was	be	AUX
bam-9817	29	35	started	start	VERB
bam-9817	29	36	.	.	PUNCT
bam-9817	30	1	hbs	hbs	PROPN
bam-9817	30	2	-	-	PUNCT
bam-9817	30	3	ag	ag	PROPN
bam-9817	30	4	,	,	PUNCT
bam-9817	30	5	hbs	hbs	PROPN
bam-9817	30	6	-	-	PUNCT
bam-9817	30	7	ab	ab	PROPN
bam-9817	30	8	,	,	PUNCT
bam-9817	30	9	hcv	hcv	PROPN
bam-9817	30	10	-	-	PUNCT
bam-9817	30	11	ab	ab	NOUN
bam-9817	30	12	,	,	PUNCT
bam-9817	30	13	hav	hav	PROPN
bam-9817	30	14	-	-	PUNCT
bam-9817	30	15	ab	ab	PROPN
bam-9817	30	16	-	-	PUNCT
bam-9817	30	17	igm	igm	PROPN
bam-9817	30	18	,	,	PUNCT
bam-9817	30	19	hiv	hiv	PROPN
bam-9817	30	20	-	-	PUNCT
bam-9817	30	21	ab	ab	PROPN
bam-9817	30	22	,	,	PUNCT
bam-9817	30	23	cmv	cmv	PROPN
bam-9817	30	24	-	-	PUNCT
bam-9817	30	25	ab	ab	PROPN
bam-9817	30	26	-	-	PUNCT
bam-9817	30	27	igm	igm	PROPN
bam-9817	30	28	,	,	PUNCT
bam-9817	30	29	ebv	ebv	PROPN
bam-9817	30	30	-	-	PUNCT
bam-9817	30	31	ab	ab	NOUN
bam-9817	30	32	-	-	PUNCT
bam-9817	30	33	igm	igm	PROPN
bam-9817	30	34	,	,	PUNCT
bam-9817	30	35	hsv	hsv	PROPN
bam-9817	30	36	-	-	PUNCT
bam-9817	30	37	i&ii	i&ii	NOUN
bam-9817	30	38	-	-	PUNCT
bam-9817	30	39	ab	ab	NOUN
bam-9817	30	40	,	,	PUNCT
bam-9817	30	41	ana	ana	PROPN
bam-9817	30	42	,	,	PUNCT
bam-9817	30	43	ama	ama	PROPN
bam-9817	30	44	,	,	PUNCT
bam-9817	30	45	asma	asma	PROPN
bam-9817	30	46	were	be	AUX
bam-9817	30	47	checked	check	VERB
bam-9817	30	48	and	and	CCONJ
bam-9817	30	49	they	they	PRON
bam-9817	30	50	were	be	AUX
bam-9817	30	51	all	all	ADV
bam-9817	30	52	negative	negative	ADJ
bam-9817	30	53	.	.	PUNCT
bam-9817	31	1	imaging	imaging	NOUN
bam-9817	31	2	studies	study	NOUN
bam-9817	31	3	were	be	AUX
bam-9817	31	4	suggestive	suggestive	ADJ
bam-9817	31	5	of	of	ADP
bam-9817	31	6	moderate	moderate	ADJ
bam-9817	31	7	hepatomegaly	hepatomegaly	NOUN
bam-9817	31	8	with	with	ADP
bam-9817	31	9	diffuse	diffuse	ADJ
bam-9817	31	10	parenchymal	parenchymal	ADJ
bam-9817	31	11	infiltration	infiltration	NOUN
bam-9817	31	12	.	.	PUNCT
bam-9817	32	1	due	due	ADP
bam-9817	32	2	to	to	ADP
bam-9817	32	3	the	the	DET
bam-9817	32	4	patient	patient	NOUN
bam-9817	32	5	’s	’s	PART
bam-9817	32	6	thrombocytopenia	thrombocytopenia	NOUN
bam-9817	32	7	and	and	CCONJ
bam-9817	32	8	elevated	elevate	VERB
bam-9817	32	9	prothrombin	prothrombin	ADJ
bam-9817	32	10	time	time	NOUN
bam-9817	32	11	,	,	PUNCT
bam-9817	32	12	liver	liver	NOUN
bam-9817	32	13	biopsy	biopsy	NOUN
bam-9817	32	14	was	be	AUX
bam-9817	32	15	not	not	PART
bam-9817	32	16	performed	perform	VERB
bam-9817	32	17	.	.	PUNCT
bam-9817	33	1	on	on	ADP
bam-9817	33	2	day	day	NOUN
bam-9817	33	3	17	17	NUM
bam-9817	33	4	after	after	ADP
bam-9817	33	5	admission	admission	NOUN
bam-9817	33	6	,	,	PUNCT
bam-9817	33	7	the	the	DET
bam-9817	33	8	o₂	o₂	PROPN
bam-9817	33	9	saturations	saturation	NOUN
bam-9817	33	10	dropped	drop	VERB
bam-9817	33	11	to	to	ADP
bam-9817	33	12	70	70	NUM
bam-9817	33	13	%	%	NOUN
bam-9817	33	14	and	and	CCONJ
bam-9817	33	15	a	a	DET
bam-9817	33	16	chest	chest	NOUN
bam-9817	33	17	ct	ct	NOUN
bam-9817	33	18	-	-	PUNCT
bam-9817	33	19	scan	scan	PROPN
bam-9817	33	20	was	be	AUX
bam-9817	33	21	requested	request	VERB
bam-9817	33	22	and	and	CCONJ
bam-9817	33	23	done	do	VERB
bam-9817	33	24	,	,	PUNCT
bam-9817	33	25	which	which	PRON
bam-9817	33	26	was	be	AUX
bam-9817	33	27	suggestive	suggestive	ADJ
bam-9817	33	28	of	of	ADP
bam-9817	33	29	covid-19	covid-19	PROPN
bam-9817	33	30	infection	infection	NOUN
bam-9817	33	31	(	(	PUNCT
bam-9817	33	32	figure	figure	NOUN
bam-9817	33	33	1	1	NUM
bam-9817	33	34	.	.	PUNCT
bam-9817	33	35	bottom	bottom	ADJ
bam-9817	33	36	left	leave	VERB
bam-9817	33	37	panel	panel	NOUN
bam-9817	33	38	)	)	PUNCT
bam-9817	33	39	and	and	CCONJ
bam-9817	33	40	later	later	ADV
bam-9817	33	41	the	the	DET
bam-9817	33	42	pcr	pcr	ADJ
bam-9817	33	43	test	test	NOUN
bam-9817	33	44	was	be	AUX
bam-9817	33	45	positive	positive	ADJ
bam-9817	33	46	for	for	ADP
bam-9817	33	47	sarscov-2	sarscov-2	PROPN
bam-9817	33	48	.	.	PUNCT
bam-9817	34	1	on	on	ADP
bam-9817	34	2	day	day	NOUN
bam-9817	34	3	20	20	NUM
bam-9817	34	4	,	,	PUNCT
bam-9817	34	5	the	the	DET
bam-9817	34	6	patient	patient	NOUN
bam-9817	34	7	was	be	AUX
bam-9817	34	8	transported	transport	VERB
bam-9817	34	9	to	to	ADP
bam-9817	34	10	the	the	DET
bam-9817	34	11	intensive	intensive	ADJ
bam-9817	34	12	care	care	NOUN
bam-9817	34	13	unit	unit	NOUN
bam-9817	34	14	and	and	CCONJ
bam-9817	34	15	unfortunately	unfortunately	ADV
bam-9817	34	16	,	,	PUNCT
bam-9817	34	17	2	2	NUM
bam-9817	34	18	days	day	NOUN
bam-9817	34	19	later	later	ADV
bam-9817	34	20	expired	expire	VERB
bam-9817	34	21	due	due	ADP
bam-9817	34	22	to	to	ADP
bam-9817	34	23	multiple	multiple	ADJ
bam-9817	34	24	organ	organ	NOUN
bam-9817	34	25	failure	failure	NOUN
bam-9817	34	26	.	.	PUNCT
bam-9817	35	1	the	the	DET
bam-9817	35	2	patient	patient	NOUN
bam-9817	35	3	’s	’s	PART
bam-9817	35	4	family	family	NOUN
bam-9817	35	5	did	do	AUX
bam-9817	35	6	not	not	PART
bam-9817	35	7	consent	consent	VERB
bam-9817	35	8	for	for	ADP
bam-9817	35	9	an	an	DET
bam-9817	35	10	autopsy	autopsy	NOUN
bam-9817	35	11	so	so	SCONJ
bam-9817	35	12	it	it	PRON
bam-9817	35	13	was	be	AUX
bam-9817	35	14	not	not	PART
bam-9817	35	15	performed	perform	VERB
bam-9817	35	16	.	.	PUNCT
bam-9817	36	1	the	the	DET
bam-9817	36	2	detailed	detailed	ADJ
bam-9817	36	3	trends	trend	NOUN
bam-9817	36	4	of	of	ADP
bam-9817	36	5	laboratory	laboratory	NOUN
bam-9817	36	6	analises	analise	NOUN
bam-9817	36	7	are	be	AUX
bam-9817	36	8	shown	show	VERB
bam-9817	36	9	in	in	ADP
bam-9817	36	10	(	(	PUNCT
bam-9817	36	11	figure	figure	NOUN
bam-9817	36	12	1	1	NUM
bam-9817	36	13	,	,	PUNCT
bam-9817	36	14	bottom	bottom	ADJ
bam-9817	36	15	right	right	ADJ
bam-9817	36	16	panel	panel	NOUN
bam-9817	36	17	)	)	PUNCT
bam-9817	36	18	.	.	PUNCT
bam-9817	37	1	discussion	discussion	NOUN
bam-9817	37	2	previous	previous	ADJ
bam-9817	37	3	reports	report	NOUN
bam-9817	37	4	show	show	VERB
bam-9817	37	5	either	either	CCONJ
bam-9817	37	6	a	a	DET
bam-9817	37	7	cholestatic	cholestatic	ADJ
bam-9817	37	8	pattern	pattern	NOUN
bam-9817	37	9	or	or	CCONJ
bam-9817	37	10	a	a	DET
bam-9817	37	11	transaminitis	transaminitis	NOUN
bam-9817	37	12	picture,1	picture,1	NOUN
bam-9817	37	13	-	-	PUNCT
bam-9817	37	14	4	4	NUM
bam-9817	37	15	but	but	CCONJ
bam-9817	37	16	in	in	ADP
bam-9817	37	17	this	this	DET
bam-9817	37	18	case	case	NOUN
bam-9817	37	19	,	,	PUNCT
bam-9817	37	20	we	we	PRON
bam-9817	37	21	are	be	AUX
bam-9817	37	22	reporting	report	VERB
bam-9817	37	23	a	a	DET
bam-9817	37	24	previously	previously	ADV
bam-9817	37	25	undescribed	undescribed	ADJ
bam-9817	37	26	isolated	isolated	ADJ
bam-9817	37	27	hyperbilirubinemia	hyperbilirubinemia	NOUN
bam-9817	37	28	as	as	ADP
bam-9817	37	29	the	the	DET
bam-9817	37	30	presentation	presentation	NOUN
bam-9817	37	31	of	of	ADP
bam-9817	37	32	the	the	DET
bam-9817	37	33	acute	acute	ADJ
bam-9817	37	34	liver	liver	NOUN
bam-9817	37	35	failure	failure	NOUN
bam-9817	37	36	in	in	ADP
bam-9817	37	37	the	the	DET
bam-9817	37	38	setting	setting	NOUN
bam-9817	37	39	of	of	ADP
bam-9817	37	40	aml	aml	PROPN
bam-9817	37	41	liver	liver	NOUN
bam-9817	37	42	involvement	involvement	NOUN
bam-9817	37	43	.	.	PUNCT
bam-9817	38	1	on	on	ADP
bam-9817	38	2	another	another	DET
bam-9817	38	3	aspect	aspect	NOUN
bam-9817	38	4	,	,	PUNCT
bam-9817	38	5	the	the	DET
bam-9817	38	6	patient	patient	NOUN
bam-9817	38	7	tested	test	VERB
bam-9817	38	8	positive	positive	ADJ
bam-9817	38	9	for	for	ADP
bam-9817	38	10	sars	sar	NOUN
bam-9817	38	11	-	-	PUNCT
bam-9817	38	12	cov-2	cov-2	NUM
bam-9817	38	13	which	which	PRON
bam-9817	38	14	raised	raise	VERB
bam-9817	38	15	some	some	DET
bam-9817	38	16	questions	question	NOUN
bam-9817	38	17	about	about	ADP
bam-9817	38	18	the	the	DET
bam-9817	38	19	causality	causality	NOUN
bam-9817	38	20	,	,	PUNCT
bam-9817	38	21	triggers	trigger	NOUN
bam-9817	38	22	,	,	PUNCT
bam-9817	38	23	and	and	CCONJ
bam-9817	38	24	risk	risk	NOUN
bam-9817	38	25	factors	factor	NOUN
bam-9817	38	26	of	of	ADP
bam-9817	38	27	acute	acute	ADJ
bam-9817	38	28	liver	liver	NOUN
bam-9817	38	29	failure	failure	NOUN
bam-9817	38	30	.	.	PUNCT
bam-9817	39	1	considering	consider	VERB
bam-9817	39	2	the	the	DET
bam-9817	39	3	rapid	rapid	ADJ
bam-9817	39	4	progress	progress	NOUN
bam-9817	39	5	of	of	ADP
bam-9817	39	6	hepatic	hepatic	ADJ
bam-9817	39	7	failure	failure	NOUN
bam-9817	39	8	,	,	PUNCT
bam-9817	39	9	we	we	PRON
bam-9817	39	10	speculated	speculate	VERB
bam-9817	39	11	that	that	SCONJ
bam-9817	39	12	covid-19	covid-19	PROPN
bam-9817	39	13	infection	infection	NOUN
bam-9817	39	14	could	could	AUX
bam-9817	39	15	play	play	VERB
bam-9817	39	16	a	a	DET
bam-9817	39	17	role	role	NOUN
bam-9817	39	18	in	in	ADP
bam-9817	39	19	exacerbating	exacerbate	VERB
bam-9817	39	20	or	or	CCONJ
bam-9817	39	21	triggering	trigger	VERB
bam-9817	39	22	the	the	DET
bam-9817	39	23	condition	condition	NOUN
bam-9817	39	24	.	.	PUNCT
bam-9817	40	1	in	in	ADP
bam-9817	40	2	a	a	DET
bam-9817	40	3	large	large	ADJ
bam-9817	40	4	u.s	u.s	PROPN
bam-9817	40	5	.	.	PROPN
bam-9817	40	6	cohort	cohort	PROPN
bam-9817	40	7	study	study	PROPN
bam-9817	40	8	,	,	PUNCT
bam-9817	40	9	phipps	phipps	PROPN
bam-9817	40	10	et	et	PROPN
bam-9817	40	11	al	al	PROPN
bam-9817	40	12	.	.	PROPN
bam-9817	40	13	,5	,5	PUNCT
bam-9817	40	14	demonstrated	demonstrate	VERB
bam-9817	40	15	that	that	SCONJ
bam-9817	40	16	acute	acute	ADJ
bam-9817	40	17	liver	liver	NOUN
bam-9817	40	18	injury	injury	NOUN
bam-9817	40	19	is	be	AUX
bam-9817	40	20	common	common	ADJ
bam-9817	40	21	in	in	ADP
bam-9817	40	22	fig	fig	NOUN
bam-9817	40	23	1	1	NUM
bam-9817	40	24	.	.	PUNCT
bam-9817	40	25	upper	upper	ADJ
bam-9817	40	26	left	left	ADJ
bam-9817	40	27	panel	panel	NOUN
bam-9817	40	28	:	:	PUNCT
bam-9817	40	29	bone	bone	NOUN
bam-9817	40	30	marrow	marrow	NOUN
bam-9817	40	31	aspiration	aspiration	NOUN
bam-9817	40	32	.	.	PUNCT
bam-9817	41	1	myeloblasts	myeloblast	NOUN
bam-9817	41	2	in	in	ADP
bam-9817	41	3	high	high	ADJ
bam-9817	41	4	-	-	PUNCT
bam-9817	41	5	power	power	NOUN
bam-9817	41	6	field	field	NOUN
bam-9817	41	7	of	of	ADP
bam-9817	41	8	microscope	microscope	NOUN
bam-9817	41	9	.	.	PUNCT
bam-9817	42	1	there	there	PRON
bam-9817	42	2	was	be	VERB
bam-9817	42	3	nearly	nearly	ADV
bam-9817	42	4	40	40	NUM
bam-9817	42	5	percent	percent	NOUN
bam-9817	42	6	myeloblasts	myeloblast	NOUN
bam-9817	42	7	in	in	ADP
bam-9817	42	8	marrow	marrow	NOUN
bam-9817	42	9	of	of	ADP
bam-9817	42	10	this	this	DET
bam-9817	42	11	patient	patient	NOUN
bam-9817	42	12	.	.	PUNCT
bam-9817	43	1	upper	upper	ADJ
bam-9817	43	2	right	right	ADJ
bam-9817	43	3	panel	panel	NOUN
bam-9817	43	4	:	:	PUNCT
bam-9817	43	5	international	international	ADJ
bam-9817	43	6	normalized	normalize	VERB
bam-9817	43	7	ratio	ratio	NOUN
bam-9817	43	8	;	;	PUNCT
bam-9817	43	9	bottom	bottom	ADJ
bam-9817	43	10	left	leave	VERB
bam-9817	43	11	panel	panel	NOUN
bam-9817	43	12	:	:	PUNCT
bam-9817	43	13	ground	ground	NOUN
bam-9817	43	14	glass	glass	NOUN
bam-9817	43	15	opacity	opacity	NOUN
bam-9817	43	16	in	in	ADP
bam-9817	43	17	peripheral	peripheral	ADJ
bam-9817	43	18	aspects	aspect	NOUN
bam-9817	43	19	of	of	ADP
bam-9817	43	20	both	both	DET
bam-9817	43	21	lungs	lung	NOUN
bam-9817	43	22	highly	highly	ADV
bam-9817	43	23	suggestive	suggestive	ADJ
bam-9817	43	24	of	of	ADP
bam-9817	43	25	covid-19	covid-19	PROPN
bam-9817	43	26	pneumonia	pneumonia	NOUN
bam-9817	43	27	.	.	PUNCT
bam-9817	44	1	bottom	bottom	ADJ
bam-9817	44	2	right	right	ADJ
bam-9817	44	3	panel	panel	NOUN
bam-9817	44	4	:	:	PUNCT
bam-9817	44	5	d	d	X
bam-9817	44	6	)	)	PUNCT
bam-9817	44	7	ast	ast	ADJ
bam-9817	44	8	,	,	PUNCT
bam-9817	44	9	alt	alt	ADJ
bam-9817	44	10	,	,	PUNCT
bam-9817	44	11	alk.p	alk.p	PROPN
bam-9817	44	12	,	,	PUNCT
bam-9817	44	13	total	total	ADJ
bam-9817	44	14	bilirubin	bilirubin	NOUN
bam-9817	44	15	and	and	CCONJ
bam-9817	44	16	direct	direct	ADJ
bam-9817	44	17	bilirubin	bilirubin	NOUN
bam-9817	44	18	levels	level	NOUN
bam-9817	44	19	acute	acute	VERB
bam-9817	44	20	myelogenous	myelogenous	ADJ
bam-9817	44	21	leukemia	leukemia	NOUN
bam-9817	44	22	and	and	CCONJ
bam-9817	44	23	covid-19	covid-19	PROPN
bam-9817	44	24	infection	infection	NOUN
bam-9817	44	25	eur	eur	PROPN
bam-9817	44	26	j	j	PROPN
bam-9817	44	27	transl	transl	PROPN
bam-9817	44	28	myol	myol	ADV
bam-9817	44	29	31	31	NUM
bam-9817	44	30	(	(	PUNCT
bam-9817	44	31	3	3	NUM
bam-9817	44	32	):	):	PUNCT
bam-9817	44	33	9817	9817	NUM
bam-9817	44	34	,	,	PUNCT
bam-9817	44	35	2021	2021	NUM
bam-9817	44	36	doi	doi	NOUN
bam-9817	44	37	:	:	PUNCT
bam-9817	44	38	10.4081	10.4081	NUM
bam-9817	44	39	/	/	SYM
bam-9817	44	40	ejtm.2021.9817	ejtm.2021.9817	NOUN
bam-9817	44	41	3	3	NUM
bam-9817	44	42	patients	patient	NOUN
bam-9817	44	43	who	who	PRON
bam-9817	44	44	test	test	VERB
bam-9817	44	45	positive	positive	ADJ
bam-9817	44	46	for	for	ADP
bam-9817	44	47	sars‐cov‐2	sars‐cov‐2	PROPN
bam-9817	44	48	,	,	PUNCT
bam-9817	44	49	but	but	CCONJ
bam-9817	44	50	it	it	PRON
bam-9817	44	51	is	be	AUX
bam-9817	44	52	most	most	ADV
bam-9817	44	53	often	often	ADV
bam-9817	44	54	mild	mild	ADJ
bam-9817	44	55	.	.	PUNCT
bam-9817	45	1	however	however	ADV
bam-9817	45	2	,	,	PUNCT
bam-9817	45	3	6.4	6.4	NUM
bam-9817	45	4	%	%	NOUN
bam-9817	45	5	of	of	ADP
bam-9817	45	6	patients	patient	NOUN
bam-9817	45	7	had	have	VERB
bam-9817	45	8	a	a	DET
bam-9817	45	9	severe	severe	ADJ
bam-9817	45	10	liver	liver	NOUN
bam-9817	45	11	injury	injury	NOUN
bam-9817	45	12	,	,	PUNCT
bam-9817	45	13	with	with	ADP
bam-9817	45	14	a	a	DET
bam-9817	45	15	severe	severe	ADJ
bam-9817	45	16	disease	disease	NOUN
bam-9817	45	17	course.5	course.5	VERB
bam-9817	45	18	a	a	DET
bam-9817	45	19	largely	largely	ADV
bam-9817	45	20	hepatocellular	hepatocellular	ADJ
bam-9817	45	21	pattern	pattern	NOUN
bam-9817	45	22	of	of	ADP
bam-9817	45	23	liver	liver	NOUN
bam-9817	45	24	injury	injury	NOUN
bam-9817	45	25	with	with	ADP
bam-9817	45	26	few	few	ADJ
bam-9817	45	27	patients	patient	NOUN
bam-9817	45	28	with	with	ADP
bam-9817	45	29	elevated	elevated	ADJ
bam-9817	45	30	bilirubin	bilirubin	NOUN
bam-9817	45	31	and/or	and/or	CCONJ
bam-9817	45	32	elevated	elevated	ADJ
bam-9817	45	33	alkaline	alkaline	NOUN
bam-9817	45	34	phosphatase	phosphatase	NOUN
bam-9817	45	35	was	be	AUX
bam-9817	45	36	observed	observe	VERB
bam-9817	45	37	.	.	PUNCT
bam-9817	46	1	significant	significant	ADJ
bam-9817	46	2	hypoalbuminemia	hypoalbuminemia	NOUN
bam-9817	46	3	was	be	AUX
bam-9817	46	4	seen	see	VERB
bam-9817	46	5	,	,	PUNCT
bam-9817	46	6	particularly	particularly	ADV
bam-9817	46	7	among	among	ADP
bam-9817	46	8	patients	patient	NOUN
bam-9817	46	9	with	with	ADP
bam-9817	46	10	severe	severe	ADJ
bam-9817	46	11	liver	liver	NOUN
bam-9817	46	12	injury	injury	NOUN
bam-9817	46	13	.	.	PUNCT
bam-9817	47	1	they	they	PRON
bam-9817	47	2	additionally	additionally	ADV
bam-9817	47	3	report	report	VERB
bam-9817	47	4	that	that	SCONJ
bam-9817	47	5	bilirubin	bilirubin	NOUN
bam-9817	47	6	was	be	AUX
bam-9817	47	7	often	often	ADV
bam-9817	47	8	normal	normal	ADJ
bam-9817	47	9	even	even	ADV
bam-9817	47	10	in	in	ADP
bam-9817	47	11	extreme	extreme	ADJ
bam-9817	47	12	cases,5	cases,5	NOUN
bam-9817	47	13	unlike	unlike	ADP
bam-9817	47	14	the	the	DET
bam-9817	47	15	situation	situation	NOUN
bam-9817	47	16	of	of	ADP
bam-9817	47	17	our	our	PRON
bam-9817	47	18	patient	patient	NOUN
bam-9817	47	19	.	.	PUNCT
bam-9817	48	1	that	that	DET
bam-9817	48	2	cohort	cohort	NOUN
bam-9817	48	3	study	study	NOUN
bam-9817	48	4	shows	show	VERB
bam-9817	48	5	a	a	DET
bam-9817	48	6	hepatocellular	hepatocellular	ADJ
bam-9817	48	7	pattern	pattern	NOUN
bam-9817	48	8	as	as	ADP
bam-9817	48	9	the	the	DET
bam-9817	48	10	manifestation	manifestation	NOUN
bam-9817	48	11	of	of	ADP
bam-9817	48	12	liver	liver	NOUN
bam-9817	48	13	involvement	involvement	NOUN
bam-9817	48	14	in	in	ADP
bam-9817	48	15	covid-19	covid-19	PROPN
bam-9817	48	16	infection,5	infection,5	NOUN
bam-9817	48	17	which	which	PRON
bam-9817	48	18	differs	differ	VERB
bam-9817	48	19	from	from	ADP
bam-9817	48	20	our	our	PRON
bam-9817	48	21	case	case	NOUN
bam-9817	48	22	’s	’s	PART
bam-9817	48	23	presentation	presentation	NOUN
bam-9817	48	24	,	,	PUNCT
bam-9817	48	25	but	but	CCONJ
bam-9817	48	26	it	it	PRON
bam-9817	48	27	also	also	ADV
bam-9817	48	28	demonstrates	demonstrate	VERB
bam-9817	48	29	that	that	SCONJ
bam-9817	48	30	liver	liver	NOUN
bam-9817	48	31	injury	injury	NOUN
bam-9817	48	32	is	be	AUX
bam-9817	48	33	common	common	ADJ
bam-9817	48	34	among	among	ADP
bam-9817	48	35	covid-19	covid-19	PROPN
bam-9817	48	36	patients	patient	NOUN
bam-9817	48	37	.	.	PUNCT
bam-9817	49	1	the	the	DET
bam-9817	49	2	mechanism	mechanism	NOUN
bam-9817	49	3	of	of	ADP
bam-9817	49	4	liver	liver	NOUN
bam-9817	49	5	injury	injury	NOUN
bam-9817	49	6	remains	remain	VERB
bam-9817	49	7	largely	largely	ADV
bam-9817	49	8	unknown	unknown	ADJ
bam-9817	49	9	and	and	CCONJ
bam-9817	49	10	is	be	AUX
bam-9817	49	11	thought	think	VERB
bam-9817	49	12	to	to	PART
bam-9817	49	13	be	be	AUX
bam-9817	49	14	a	a	DET
bam-9817	49	15	combination	combination	NOUN
bam-9817	49	16	of	of	ADP
bam-9817	49	17	both	both	CCONJ
bam-9817	49	18	direct	direct	ADJ
bam-9817	49	19	virally	virally	ADV
bam-9817	49	20	-	-	PUNCT
bam-9817	49	21	mediated	mediate	VERB
bam-9817	49	22	effects	effect	NOUN
bam-9817	49	23	as	as	ADV
bam-9817	49	24	well	well	ADV
bam-9817	49	25	as	as	ADP
bam-9817	49	26	a	a	DET
bam-9817	49	27	result	result	NOUN
bam-9817	49	28	of	of	ADP
bam-9817	49	29	the	the	DET
bam-9817	49	30	immune	immune	ADJ
bam-9817	49	31	response.6,7	response.6,7	PROPN
bam-9817	49	32	viral	viral	ADJ
bam-9817	49	33	infections	infection	NOUN
bam-9817	49	34	are	be	AUX
bam-9817	49	35	predominant	predominant	ADJ
bam-9817	49	36	causes	cause	NOUN
bam-9817	49	37	of	of	ADP
bam-9817	49	38	acute	acute	ADJ
bam-9817	49	39	liver	liver	NOUN
bam-9817	49	40	failure	failure	NOUN
bam-9817	49	41	in	in	ADP
bam-9817	49	42	developing	develop	VERB
bam-9817	49	43	countries	country	NOUN
bam-9817	49	44	,	,	PUNCT
bam-9817	49	45	especially	especially	ADV
bam-9817	49	46	hepatitis	hepatitis	PROPN
bam-9817	49	47	a	a	PROPN
bam-9817	49	48	,	,	PUNCT
bam-9817	49	49	b	b	NOUN
bam-9817	49	50	,	,	PUNCT
bam-9817	49	51	and	and	CCONJ
bam-9817	49	52	e	e	X
bam-9817	49	53	viruses.1	viruses.1	NOUN
bam-9817	49	54	it	it	PRON
bam-9817	49	55	is	be	AUX
bam-9817	49	56	clear	clear	ADJ
bam-9817	49	57	that	that	SCONJ
bam-9817	49	58	covid-19	covid-19	PROPN
bam-9817	49	59	infection	infection	NOUN
bam-9817	49	60	can	can	AUX
bam-9817	49	61	also	also	ADV
bam-9817	49	62	damage	damage	VERB
bam-9817	49	63	the	the	DET
bam-9817	49	64	liver	liver	NOUN
bam-9817	49	65	tissue	tissue	NOUN
bam-9817	49	66	and	and	CCONJ
bam-9817	49	67	in	in	ADP
bam-9817	49	68	theory	theory	NOUN
bam-9817	49	69	,	,	PUNCT
bam-9817	49	70	it	it	PRON
bam-9817	49	71	could	could	AUX
bam-9817	49	72	at	at	ADP
bam-9817	49	73	least	least	ADJ
bam-9817	49	74	worsen	worsen	VERB
bam-9817	49	75	the	the	DET
bam-9817	49	76	progression	progression	NOUN
bam-9817	49	77	of	of	ADP
bam-9817	49	78	liver	liver	NOUN
bam-9817	49	79	failure	failure	NOUN
bam-9817	49	80	.	.	PUNCT
bam-9817	50	1	however	however	ADV
bam-9817	50	2	,	,	PUNCT
bam-9817	50	3	it	it	PRON
bam-9817	50	4	remains	remain	VERB
bam-9817	50	5	unclear	unclear	ADJ
bam-9817	50	6	if	if	SCONJ
bam-9817	50	7	this	this	DET
bam-9817	50	8	infection	infection	NOUN
bam-9817	50	9	could	could	AUX
bam-9817	50	10	cause	cause	VERB
bam-9817	50	11	in	in	ADP
bam-9817	50	12	the	the	DET
bam-9817	50	13	already	already	ADV
bam-9817	50	14	susceptible	susceptible	ADJ
bam-9817	50	15	liver	liver	NOUN
bam-9817	50	16	to	to	PART
bam-9817	50	17	fail	fail	VERB
bam-9817	50	18	or	or	CCONJ
bam-9817	50	19	it	it	PRON
bam-9817	50	20	is	be	AUX
bam-9817	50	21	a	a	DET
bam-9817	50	22	risk	risk	NOUN
bam-9817	50	23	factor	factor	NOUN
bam-9817	50	24	of	of	ADP
bam-9817	50	25	fulminant	fulminant	ADJ
bam-9817	50	26	hepatic	hepatic	ADJ
bam-9817	50	27	failure	failure	NOUN
bam-9817	50	28	.	.	PUNCT
bam-9817	51	1	isolated	isolated	ADJ
bam-9817	51	2	hyperbilirubinemia	hyperbilirubinemia	NOUN
bam-9817	51	3	is	be	AUX
bam-9817	51	4	a	a	DET
bam-9817	51	5	very	very	ADV
bam-9817	51	6	rare	rare	ADJ
bam-9817	51	7	presentation	presentation	NOUN
bam-9817	51	8	of	of	ADP
bam-9817	51	9	the	the	DET
bam-9817	51	10	rare	rare	ADJ
bam-9817	51	11	acute	acute	ADJ
bam-9817	51	12	liver	liver	NOUN
bam-9817	51	13	failure	failure	NOUN
bam-9817	51	14	syndrome	syndrome	NOUN
bam-9817	51	15	.	.	PUNCT
bam-9817	52	1	in	in	ADP
bam-9817	52	2	our	our	PRON
bam-9817	52	3	investigations	investigation	NOUN
bam-9817	52	4	,	,	PUNCT
bam-9817	52	5	we	we	PRON
bam-9817	52	6	found	find	VERB
bam-9817	52	7	two	two	NUM
bam-9817	52	8	possible	possible	ADJ
bam-9817	52	9	causes	cause	NOUN
bam-9817	52	10	for	for	ADP
bam-9817	52	11	this	this	DET
bam-9817	52	12	case	case	NOUN
bam-9817	52	13	.	.	PUNCT
bam-9817	53	1	firstly	firstly	ADV
bam-9817	53	2	,	,	PUNCT
bam-9817	53	3	aml	aml	PROPN
bam-9817	53	4	involvement	involvement	NOUN
bam-9817	53	5	of	of	ADP
bam-9817	53	6	the	the	DET
bam-9817	53	7	liver	liver	NOUN
bam-9817	53	8	which	which	PRON
bam-9817	53	9	is	be	AUX
bam-9817	53	10	also	also	ADV
bam-9817	53	11	uncommon	uncommon	ADJ
bam-9817	53	12	.	.	PUNCT
bam-9817	54	1	secondly	secondly	ADV
bam-9817	54	2	,	,	PUNCT
bam-9817	54	3	covid-19	covid-19	PROPN
bam-9817	54	4	infection	infection	NOUN
bam-9817	54	5	which	which	PRON
bam-9817	54	6	can	can	AUX
bam-9817	54	7	cause	cause	VERB
bam-9817	54	8	liver	liver	NOUN
bam-9817	54	9	injury	injury	NOUN
bam-9817	54	10	.	.	PUNCT
bam-9817	55	1	or	or	CCONJ
bam-9817	55	2	a	a	DET
bam-9817	55	3	combination	combination	NOUN
bam-9817	55	4	of	of	ADP
bam-9817	55	5	these	these	DET
bam-9817	55	6	two	two	NUM
bam-9817	55	7	that	that	PRON
bam-9817	55	8	eventually	eventually	ADV
bam-9817	55	9	leads	lead	VERB
bam-9817	55	10	to	to	ADP
bam-9817	55	11	this	this	DET
bam-9817	55	12	unique	unique	ADJ
bam-9817	55	13	manifestation	manifestation	NOUN
bam-9817	55	14	of	of	ADP
bam-9817	55	15	this	this	DET
bam-9817	55	16	condition	condition	NOUN
bam-9817	55	17	.	.	PUNCT
bam-9817	56	1	in	in	ADP
bam-9817	56	2	any	any	DET
bam-9817	56	3	case	case	NOUN
bam-9817	56	4	,	,	PUNCT
bam-9817	56	5	future	future	ADJ
bam-9817	56	6	research	research	NOUN
bam-9817	56	7	with	with	ADP
bam-9817	56	8	a	a	DET
bam-9817	56	9	large	large	ADJ
bam-9817	56	10	sample	sample	NOUN
bam-9817	56	11	pool	pool	NOUN
bam-9817	56	12	,	,	PUNCT
bam-9817	56	13	case	case	NOUN
bam-9817	56	14	series	series	NOUN
bam-9817	56	15	,	,	PUNCT
bam-9817	56	16	and	and	CCONJ
bam-9817	56	17	longitudinal	longitudinal	ADJ
bam-9817	56	18	studies	study	NOUN
bam-9817	56	19	are	be	AUX
bam-9817	56	20	required	require	VERB
bam-9817	56	21	.	.	PUNCT
bam-9817	57	1	here	here	ADV
bam-9817	57	2	are	be	AUX
bam-9817	57	3	some	some	PRON
bam-9817	57	4	of	of	ADP
bam-9817	57	5	our	our	PRON
bam-9817	57	6	recommended	recommend	VERB
bam-9817	57	7	subjects	subject	NOUN
bam-9817	57	8	for	for	ADP
bam-9817	57	9	future	future	ADJ
bam-9817	57	10	research	research	NOUN
bam-9817	57	11	:	:	PUNCT
bam-9817	57	12	i	i	NOUN
bam-9817	57	13	)	)	PUNCT
bam-9817	57	14	isolated	isolated	ADJ
bam-9817	57	15	hyperbilirubinemia	hyperbilirubinemia	NOUN
bam-9817	57	16	as	as	SCONJ
bam-9817	57	17	oppose	oppose	VERB
bam-9817	57	18	to	to	ADP
bam-9817	57	19	cholestatic	cholestatic	ADJ
bam-9817	57	20	and	and	CCONJ
bam-9817	57	21	hepatocellular	hepatocellular	ADJ
bam-9817	57	22	patterns	pattern	NOUN
bam-9817	57	23	in	in	ADP
bam-9817	57	24	acute	acute	ADJ
bam-9817	57	25	liver	liver	NOUN
bam-9817	57	26	failure	failure	NOUN
bam-9817	57	27	;	;	PUNCT
bam-9817	57	28	ii	ii	X
bam-9817	57	29	)	)	PUNCT
bam-9817	57	30	liver	liver	NOUN
bam-9817	57	31	involvement	involvement	NOUN
bam-9817	57	32	and	and	CCONJ
bam-9817	57	33	acute	acute	ADJ
bam-9817	57	34	liver	liver	NOUN
bam-9817	57	35	failure	failure	NOUN
bam-9817	57	36	in	in	ADP
bam-9817	57	37	aml	aml	NOUN
bam-9817	57	38	patients	patient	NOUN
bam-9817	57	39	and	and	CCONJ
bam-9817	57	40	the	the	DET
bam-9817	57	41	response	response	NOUN
bam-9817	57	42	to	to	ADP
bam-9817	57	43	chemotherapy	chemotherapy	NOUN
bam-9817	57	44	;	;	PUNCT
bam-9817	57	45	iii	iii	X
bam-9817	57	46	)	)	PUNCT
bam-9817	57	47	acute	acute	ADJ
bam-9817	57	48	liver	liver	NOUN
bam-9817	57	49	failure	failure	NOUN
bam-9817	57	50	and	and	CCONJ
bam-9817	57	51	it	it	PRON
bam-9817	57	52	’s	’	VERB
bam-9817	57	53	risk	risk	NOUN
bam-9817	57	54	factors	factor	NOUN
bam-9817	57	55	in	in	ADP
bam-9817	57	56	covid-19	covid-19	PROPN
bam-9817	57	57	infection	infection	NOUN
bam-9817	57	58	.	.	PUNCT
bam-9817	58	1	list	list	NOUN
bam-9817	58	2	of	of	ADP
bam-9817	58	3	acronyms	acronym	NOUN
bam-9817	58	4	alf	alf	PROPN
bam-9817	58	5	:	:	PUNCT
bam-9817	58	6	acute	acute	ADJ
bam-9817	58	7	liver	liver	NOUN
bam-9817	58	8	failure	failure	NOUN
bam-9817	58	9	alk.p	alk.p	NOUN
bam-9817	58	10	:	:	PUNCT
bam-9817	58	11	alkaline	alkaline	NOUN
bam-9817	58	12	phosphatase	phosphatase	NOUN
bam-9817	58	13	alt	alt	PROPN
bam-9817	58	14	:	:	PUNCT
bam-9817	58	15	alanine	alanine	PROPN
bam-9817	58	16	aminotransferase	aminotransferase	PROPN
bam-9817	58	17	ama	ama	NOUN
bam-9817	58	18	:	:	PUNCT
bam-9817	58	19	antimitochondrial	antimitochondrial	ADJ
bam-9817	58	20	antibody	antibody	NOUN
bam-9817	58	21	aml	aml	PROPN
bam-9817	58	22	:	:	PUNCT
bam-9817	58	23	acute	acute	ADJ
bam-9817	58	24	myelogenous	myelogenous	PROPN
bam-9817	58	25	leukemia	leukemia	PROPN
bam-9817	58	26	ana	ana	PROPN
bam-9817	58	27	:	:	PUNCT
bam-9817	58	28	antinuclear	antinuclear	ADJ
bam-9817	58	29	antibody	antibody	NOUN
bam-9817	58	30	asma	asma	PROPN
bam-9817	58	31	:	:	PUNCT
bam-9817	58	32	anti	anti	ADJ
bam-9817	58	33	-	-	ADJ
bam-9817	58	34	smooth	smooth	ADJ
bam-9817	58	35	muscle	muscle	NOUN
bam-9817	58	36	antibody	antibody	NOUN
bam-9817	58	37	ast	ast	NOUN
bam-9817	58	38	:	:	PUNCT
bam-9817	58	39	aspartate	aspartate	NOUN
bam-9817	58	40	aminotransferase	aminotransferase	PROPN
bam-9817	58	41	cmv	cmv	NOUN
bam-9817	58	42	:	:	PUNCT
bam-9817	58	43	cytomegalovirus	cytomegalovirus	NOUN
bam-9817	58	44	covid-19	covid-19	PROPN
bam-9817	58	45	:	:	PUNCT
bam-9817	58	46	coronavirus	coronavirus	NOUN
bam-9817	58	47	disease	disease	NOUN
bam-9817	58	48	of	of	ADP
bam-9817	58	49	2019	2019	NUM
bam-9817	58	50	ebv	ebv	NOUN
bam-9817	58	51	:	:	PUNCT
bam-9817	58	52	epstein	epstein	PROPN
bam-9817	58	53	–	–	PUNCT
bam-9817	58	54	barr	barr	PROPN
bam-9817	58	55	virus	virus	PROPN
bam-9817	58	56	hb	hb	PROPN
bam-9817	58	57	:	:	PUNCT
bam-9817	58	58	hemoglobin	hemoglobin	PROPN
bam-9817	58	59	inr	inr	PROPN
bam-9817	58	60	:	:	PUNCT
bam-9817	58	61	international	international	PROPN
bam-9817	58	62	normalized	normalize	VERB
bam-9817	58	63	ratio	ratio	PROPN
bam-9817	58	64	nac	nac	PROPN
bam-9817	58	65	:	:	PUNCT
bam-9817	58	66	n	n	CCONJ
bam-9817	58	67	-	-	PUNCT
bam-9817	58	68	acetylcysteine	acetylcysteine	ADJ
bam-9817	58	69	pcr	pcr	NOUN
bam-9817	58	70	:	:	PUNCT
bam-9817	58	71	polymerase	polymerase	NOUN
bam-9817	58	72	chain	chain	NOUN
bam-9817	58	73	reaction	reaction	NOUN
bam-9817	58	74	plt	plt	NOUN
bam-9817	58	75	:	:	PUNCT
bam-9817	58	76	platelets	platelet	VERB
bam-9817	58	77	authors	author	NOUN
bam-9817	58	78	contributions	contribution	VERB
bam-9817	58	79	ng	ng	PROPN
bam-9817	58	80	,	,	PUNCT
bam-9817	58	81	vsa	vsa	PROPN
bam-9817	58	82	,	,	PUNCT
bam-9817	58	83	rm	rm	PROPN
bam-9817	58	84	,	,	PUNCT
bam-9817	58	85	hkh	hkh	PROPN
bam-9817	58	86	,	,	PUNCT
bam-9817	58	87	mjk	mjk	PROPN
bam-9817	58	88	participated	participate	VERB
bam-9817	58	89	in	in	ADP
bam-9817	58	90	data	datum	NOUN
bam-9817	58	91	collection	collection	NOUN
bam-9817	58	92	,	,	PUNCT
bam-9817	58	93	wrote	write	VERB
bam-9817	58	94	the	the	DET
bam-9817	58	95	manuscript	manuscript	NOUN
bam-9817	58	96	and	and	CCONJ
bam-9817	58	97	reviewed	review	VERB
bam-9817	58	98	literature	literature	NOUN
bam-9817	58	99	.	.	PUNCT
bam-9817	59	1	all	all	DET
bam-9817	59	2	authors	author	NOUN
bam-9817	59	3	critically	critically	ADV
bam-9817	59	4	reviewed	review	VERB
bam-9817	59	5	final	final	ADJ
bam-9817	59	6	draft	draft	NOUN
bam-9817	59	7	and	and	CCONJ
bam-9817	59	8	approved	approve	VERB
bam-9817	59	9	the	the	DET
bam-9817	59	10	submitted	submit	VERB
bam-9817	59	11	typescript	typescript	NOUN
bam-9817	59	12	.	.	PUNCT
bam-9817	60	1	acknowledgments	acknowledgment	NOUN
bam-9817	60	2	none	none	NOUN
bam-9817	60	3	.	.	PUNCT
bam-9817	61	1	funding	fund	VERB
bam-9817	61	2	none	none	NOUN
bam-9817	61	3	.	.	PUNCT
bam-9817	62	1	conflict	conflict	NOUN
bam-9817	62	2	of	of	ADP
bam-9817	62	3	interest	interest	NOUN
bam-9817	62	4	the	the	DET
bam-9817	62	5	author	author	NOUN
bam-9817	62	6	declares	declare	VERB
bam-9817	62	7	no	no	DET
bam-9817	62	8	competing	compete	VERB
bam-9817	62	9	interests	interest	NOUN
bam-9817	62	10	.	.	PUNCT
bam-9817	63	1	ethical	ethical	ADJ
bam-9817	63	2	publication	publication	NOUN
bam-9817	63	3	statement	statement	NOUN
bam-9817	63	4	we	we	PRON
bam-9817	63	5	confirm	confirm	VERB
bam-9817	63	6	that	that	SCONJ
bam-9817	63	7	we	we	PRON
bam-9817	63	8	have	have	AUX
bam-9817	63	9	read	read	VERB
bam-9817	63	10	the	the	DET
bam-9817	63	11	journal	journal	NOUN
bam-9817	63	12	's	's	PART
bam-9817	63	13	position	position	NOUN
bam-9817	63	14	on	on	ADP
bam-9817	63	15	the	the	DET
bam-9817	63	16	issues	issue	NOUN
bam-9817	63	17	involved	involve	VERB
bam-9817	63	18	in	in	ADP
bam-9817	63	19	ethical	ethical	ADJ
bam-9817	63	20	publication	publication	NOUN
bam-9817	63	21	and	and	CCONJ
bam-9817	63	22	affirm	affirm	NOUN
bam-9817	63	23	that	that	SCONJ
bam-9817	63	24	this	this	DET
bam-9817	63	25	report	report	NOUN
bam-9817	63	26	is	be	AUX
bam-9817	63	27	consistent	consistent	ADJ
bam-9817	63	28	with	with	ADP
bam-9817	63	29	those	those	DET
bam-9817	63	30	guidelines	guideline	NOUN
bam-9817	63	31	.	.	PUNCT
bam-9817	64	1	corresponding	correspond	VERB
bam-9817	64	2	author	author	NOUN
bam-9817	64	3	nasrin	nasrin	PROPN
bam-9817	64	4	gholami	gholami	PROPN
bam-9817	64	5	,	,	PUNCT
bam-9817	64	6	hematology	hematology	NOUN
bam-9817	64	7	oncology	oncology	NOUN
bam-9817	64	8	research	research	NOUN
bam-9817	64	9	center	center	NOUN
bam-9817	64	10	,	,	PUNCT
bam-9817	64	11	tabriz	tabriz	PROPN
bam-9817	64	12	university	university	PROPN
bam-9817	64	13	of	of	ADP
bam-9817	64	14	medical	medical	ADJ
bam-9817	64	15	sciences	sciences	PROPN
bam-9817	64	16	,	,	PUNCT
bam-9817	64	17	tabriz	tabriz	NOUN
bam-9817	64	18	,	,	PUNCT
bam-9817	64	19	iran	iran	PROPN
bam-9817	64	20	.	.	PUNCT
bam-9817	65	1	orcid	orcid	NOUN
bam-9817	66	1	i	i	PRON
bam-9817	66	2	d	d	NOUN
bam-9817	66	3	:	:	PUNCT
bam-9817	66	4	0000	0000	NUM
bam-9817	66	5	-	-	PUNCT
bam-9817	66	6	0002	0002	NUM
bam-9817	66	7	-	-	PUNCT
bam-9817	66	8	9546	9546	NUM
bam-9817	66	9	-	-	PUNCT
bam-9817	66	10	0186	0186	NUM
bam-9817	66	11	email	email	NOUN
bam-9817	66	12	:	:	PUNCT
bam-9817	66	13	dr.gholami_internist@yahoo.com	dr.gholami_internist@yahoo.com	X
bam-9817	66	14	e	e	NOUN
bam-9817	66	15	-	-	NOUN
bam-9817	66	16	mails	mail	NOUN
bam-9817	66	17	and	and	CCONJ
bam-9817	66	18	orcid	orcid	NOUN
bam-9817	67	1	i	i	INTJ
bam-9817	67	2	d	d	PROPN
bam-9817	67	3	of	of	ADP
bam-9817	67	4	coauthors	coauthor	NOUN
bam-9817	67	5	vahid	vahid	PROPN
bam-9817	67	6	sheykhzadeh	sheykhzadeh	PROPN
bam-9817	67	7	amzajerdi	amzajerdi	PROPN
bam-9817	67	8	:	:	PUNCT
bam-9817	68	1	vahidsheykh94@gmail.com	vahidsheykh94@gmail.com	X
bam-9817	68	2	orcid	orcid	NOUN
bam-9817	68	3	i	i	PRON
bam-9817	68	4	d	d	NOUN
bam-9817	68	5	:	:	PUNCT
bam-9817	68	6	0000	0000	NUM
bam-9817	68	7	-	-	PUNCT
bam-9817	68	8	0002	0002	NUM
bam-9817	68	9	-	-	PUNCT
bam-9817	68	10	3154	3154	NUM
bam-9817	68	11	-	-	SYM
bam-9817	68	12	6044	6044	NUM
bam-9817	68	13	rahim	rahim	NOUN
bam-9817	68	14	mehdioghli	mehdioghli	NOUN
bam-9817	68	15	:	:	PUNCT
bam-9817	69	1	mehdioghloorahim@gmail.com	mehdioghloorahim@gmail.com	X
bam-9817	69	2	orcid	orcid	NOUN
bam-9817	70	1	i	i	PRON
bam-9817	70	2	d	d	NOUN
bam-9817	70	3	:	:	PUNCT
bam-9817	70	4	0000	0000	NUM
bam-9817	70	5	-	-	PUNCT
bam-9817	70	6	0001	0001	NUM
bam-9817	70	7	-	-	PUNCT
bam-9817	70	8	5460	5460	NUM
bam-9817	70	9	-	-	PUNCT
bam-9817	70	10	7383	7383	NUM
bam-9817	70	11	hengameh	hengameh	NOUN
bam-9817	70	12	khadivi	khadivi	PROPN
bam-9817	70	13	heris	heris	PROPN
bam-9817	70	14	:	:	PUNCT
bam-9817	70	15	hengame.khadiviheris@gmail.com	hengame.khadiviheris@gmail.com	X
bam-9817	70	16	orcid	orcid	NOUN
bam-9817	71	1	i	i	PRON
bam-9817	71	2	d	d	NOUN
bam-9817	71	3	:	:	PUNCT
bam-9817	71	4	0000	0000	NUM
bam-9817	71	5	-	-	PUNCT
bam-9817	71	6	0002	0002	NUM
bam-9817	71	7	-	-	PUNCT
bam-9817	71	8	0501	0501	NUM
bam-9817	71	9	-	-	SYM
bam-9817	71	10	7376	7376	NUM
bam-9817	71	11	mona	mona	PROPN
bam-9817	71	12	jahandideh	jahandideh	PROPN
bam-9817	71	13	kazempour	kazempour	PROPN
bam-9817	71	14	:	:	PUNCT
bam-9817	72	1	monajahandidehkazempour@yandex.com	monajahandidehkazempour@yandex.com	X
bam-9817	72	2	orcid	orcid	PROPN
bam-9817	73	1	i	i	PRON
bam-9817	73	2	d	d	NOUN
bam-9817	73	3	:	:	PUNCT
bam-9817	73	4	0000	0000	NUM
bam-9817	73	5	-	-	PUNCT
bam-9817	73	6	0002	0002	NUM
bam-9817	73	7	-	-	PUNCT
bam-9817	73	8	8673	8673	NUM
bam-9817	73	9	-	-	PUNCT
bam-9817	73	10	0949	0949	NUM
bam-9817	73	11	references	reference	NOUN
bam-9817	73	12	1	1	NUM
bam-9817	73	13	.	.	PUNCT
bam-9817	73	14	sobotka	sobotka	PROPN
bam-9817	73	15	la	la	PROPN
bam-9817	73	16	,	,	PUNCT
bam-9817	73	17	malli	malli	PROPN
bam-9817	73	18	a	a	PROPN
bam-9817	73	19	,	,	PUNCT
bam-9817	73	20	chen	chen	PROPN
bam-9817	73	21	w	w	PROPN
bam-9817	73	22	,	,	PUNCT
bam-9817	73	23	mumtaz	mumtaz	PROPN
bam-9817	73	24	k.	k.	PROPN
bam-9817	73	25	acute	acute	PROPN
bam-9817	73	26	liver	liver	NOUN
bam-9817	73	27	failure	failure	NOUN
bam-9817	73	28	due	due	ADP
bam-9817	73	29	to	to	ADP
bam-9817	73	30	liver	liver	VERB
bam-9817	73	31	parenchymal	parenchymal	ADJ
bam-9817	73	32	infiltration	infiltration	NOUN
bam-9817	73	33	with	with	ADP
bam-9817	73	34	acute	acute	ADJ
bam-9817	73	35	myelogenous	myelogenous	ADJ
bam-9817	73	36	leukaemia	leukaemia	NOUN
bam-9817	73	37	in	in	ADP
bam-9817	73	38	a	a	DET
bam-9817	73	39	patient	patient	NOUN
bam-9817	73	40	with	with	ADP
bam-9817	73	41	myelodysplastic	myelodysplastic	ADJ
bam-9817	73	42	syndrome	syndrome	NOUN
bam-9817	73	43	.	.	PUNCT
bam-9817	74	1	bmj	bmj	PROPN
bam-9817	74	2	case	case	NOUN
bam-9817	74	3	rep	rep	PROPN
bam-9817	74	4	.	.	PROPN
bam-9817	74	5	2018	2018	NUM
bam-9817	74	6	jun	jun	PROPN
bam-9817	74	7	28;2018	28;2018	NUM
bam-9817	74	8	:	:	PUNCT
bam-9817	74	9	bcr2018224590	bcr2018224590	X
bam-9817	74	10	.	.	PUNCT
bam-9817	75	1	doi	doi	NOUN
bam-9817	75	2	:	:	PUNCT
bam-9817	75	3	10.1136	10.1136	NUM
bam-9817	75	4	/	/	SYM
bam-9817	75	5	bcr2018	bcr2018	NOUN
bam-9817	75	6	-	-	PUNCT
bam-9817	75	7	224590	224590	NUM
bam-9817	75	8	.	.	PUNCT
bam-9817	76	1	2	2	X
bam-9817	76	2	.	.	X
bam-9817	76	3	goor	goor	PROPN
bam-9817	76	4	y	y	PROPN
bam-9817	76	5	,	,	PUNCT
bam-9817	76	6	goor	goor	ADJ
bam-9817	76	7	o	o	NOUN
bam-9817	76	8	,	,	PUNCT
bam-9817	76	9	michalewitcz	michalewitcz	PROPN
bam-9817	76	10	r	r	PROPN
bam-9817	76	11	,	,	PUNCT
bam-9817	76	12	cabili	cabili	NOUN
bam-9817	76	13	s.	s.	PROPN
bam-9817	76	14	acute	acute	PROPN
bam-9817	76	15	myeloid	myeloid	PROPN
bam-9817	76	16	leukemia	leukemia	NOUN
bam-9817	76	17	presenting	present	VERB
bam-9817	76	18	as	as	ADP
bam-9817	76	19	obstructive	obstructive	ADJ
bam-9817	76	20	jaundice	jaundice	NOUN
bam-9817	76	21	.	.	PUNCT
bam-9817	77	1	j	j	PROPN
bam-9817	77	2	clin	clin	PROPN
bam-9817	77	3	gastroenterol	gastroenterol	PROPN
bam-9817	77	4	.	.	PUNCT
bam-9817	78	1	2002	2002	NUM
bam-9817	78	2	apr;34(4):4856	apr;34(4):4856	PROPN
bam-9817	78	3	.	.	PUNCT
bam-9817	79	1	doi	doi	PROPN
bam-9817	79	2	:	:	PUNCT
bam-9817	79	3	10.1097/00004836	10.1097/00004836	NUM
bam-9817	79	4	-	-	SYM
bam-9817	79	5	200204000	200204000	NUM
bam-9817	79	6	-	-	PUNCT
bam-9817	79	7	00023	00023	NUM
bam-9817	79	8	.	.	PUNCT
bam-9817	80	1	3	3	X
bam-9817	80	2	.	.	X
bam-9817	80	3	mathews	mathews	PROPN
bam-9817	80	4	e	e	PROPN
bam-9817	80	5	,	,	PUNCT
bam-9817	80	6	laurie	laurie	PROPN
bam-9817	80	7	t	t	PROPN
bam-9817	80	8	,	,	PUNCT
bam-9817	80	9	o'riordan	o'riordan	PROPN
bam-9817	80	10	k	k	PROPN
bam-9817	80	11	,	,	PUNCT
bam-9817	80	12	nabhan	nabhan	ADP
bam-9817	80	13	c.	c.	PROPN
bam-9817	80	14	liver	liver	PROPN
bam-9817	80	15	involvement	involvement	NOUN
bam-9817	80	16	with	with	ADP
bam-9817	80	17	acute	acute	ADJ
bam-9817	80	18	myeloid	myeloid	ADJ
bam-9817	80	19	leukemia	leukemia	NOUN
bam-9817	80	20	.	.	PUNCT
bam-9817	81	1	case	case	NOUN
bam-9817	81	2	rep	rep	PROPN
bam-9817	81	3	gastroenterol	gastroenterol	PROPN
bam-9817	81	4	.	.	PUNCT
bam-9817	82	1	2008	2008	NUM
bam-9817	82	2	mar	mar	PROPN
bam-9817	82	3	14;2(1):121	14;2(1):121	NUM
bam-9817	82	4	-	-	SYM
bam-9817	82	5	4	4	NUM
bam-9817	82	6	.	.	PUNCT
bam-9817	82	7	doi	doi	NOUN
bam-9817	82	8	:	:	PUNCT
bam-9817	82	9	10.1159/000120756	10.1159/000120756	NUM
bam-9817	82	10	.	.	NOUN
bam-9817	83	1	4	4	X
bam-9817	83	2	.	.	X
bam-9817	83	3	rajesh	rajesh	PROPN
bam-9817	83	4	g	g	PROPN
bam-9817	83	5	,	,	PUNCT
bam-9817	83	6	sadasivan	sadasivan	VERB
bam-9817	83	7	s	s	PRON
bam-9817	83	8	,	,	PUNCT
bam-9817	83	9	hiran	hiran	ADJ
bam-9817	83	10	kr	kr	PROPN
bam-9817	83	11	,	,	PUNCT
bam-9817	83	12	nandakumar	nandakumar	PROPN
bam-9817	83	13	r	r	PROPN
bam-9817	83	14	,	,	PUNCT
bam-9817	83	15	balakrishnan	balakrishnan	PROPN
bam-9817	83	16	v.	v.	ADP
bam-9817	83	17	acute	acute	PROPN
bam-9817	83	18	myeloid	myeloid	PROPN
bam-9817	83	19	leukemia	leukemia	NOUN
bam-9817	83	20	presenting	present	VERB
bam-9817	83	21	as	as	ADP
bam-9817	83	22	obstructive	obstructive	ADJ
bam-9817	83	23	jaundice	jaundice	NOUN
bam-9817	83	24	.	.	PUNCT
bam-9817	84	1	indian	indian	PROPN
bam-9817	84	2	j	j	PROPN
bam-9817	84	3	gastroenterol	gastroenterol	PROPN
bam-9817	84	4	.	.	PUNCT
bam-9817	85	1	2006	2006	NUM
bam-9817	85	2	mar	mar	PROPN
bam-9817	85	3	-	-	PUNCT
bam-9817	85	4	apr;25(2):93	apr;25(2):93	PROPN
bam-9817	85	5	-	-	PUNCT
bam-9817	85	6	4	4	NUM
bam-9817	85	7	.	.	NOUN
bam-9817	85	8	5	5	NUM
bam-9817	85	9	.	.	PUNCT
bam-9817	85	10	phipps	phipps	PROPN
bam-9817	85	11	mm	mm	PROPN
bam-9817	85	12	,	,	PUNCT
bam-9817	85	13	barraza	barraza	PROPN
bam-9817	85	14	lh	lh	PROPN
bam-9817	85	15	,	,	PUNCT
bam-9817	85	16	lasota	lasota	PROPN
bam-9817	85	17	ed	ed	PROPN
bam-9817	85	18	,	,	PUNCT
bam-9817	85	19	sobieszczyk	sobieszczyk	VERB
bam-9817	85	20	me	i	PRON
bam-9817	85	21	,	,	PUNCT
bam-9817	85	22	pereira	pereira	PROPN
bam-9817	85	23	mr	mr	PROPN
bam-9817	85	24	,	,	PUNCT
bam-9817	85	25	zheng	zheng	PROPN
bam-9817	85	26	ex	ex	PROPN
bam-9817	85	27	,	,	PUNCT
bam-9817	85	28	fox	fox	PROPN
bam-9817	85	29	an	an	PROPN
bam-9817	85	30	,	,	PUNCT
bam-9817	85	31	zucker	zucker	PROPN
bam-9817	85	32	j	j	PROPN
bam-9817	85	33	,	,	PUNCT
bam-9817	85	34	verna	verna	PROPN
bam-9817	85	35	ec	ec	PROPN
bam-9817	85	36	.	.	PUNCT
bam-9817	86	1	acute	acute	PROPN
bam-9817	86	2	liver	liver	NOUN
bam-9817	86	3	injury	injury	NOUN
bam-9817	86	4	in	in	ADP
bam-9817	86	5	covid-19	covid-19	PROPN
bam-9817	86	6	:	:	PUNCT
bam-9817	87	1	mailto:dr.gholami_internist@yahoo.com	mailto:dr.gholami_internist@yahoo.com	PROPN
bam-9817	87	2	mailto:vahidsheykh94@gmail.com	mailto:vahidsheykh94@gmail.com	PROPN
bam-9817	87	3	mailto:mehdioghloorahim@gmail.com	mailto:mehdioghloorahim@gmail.com	PROPN
bam-9817	87	4	mailto:hengame.khadiviheris@gmail.com	mailto:hengame.khadiviheris@gmail.com	PROPN
bam-9817	88	1	mailto:monajahandidehkazempour@yandex.com	mailto:monajahandidehkazempour@yandex.com	X
bam-9817	89	1	acute	acute	ADJ
bam-9817	89	2	myelogenous	myelogenous	ADJ
bam-9817	89	3	leukemia	leukemia	PROPN
bam-9817	89	4	and	and	CCONJ
bam-9817	89	5	covid-19	covid-19	PROPN
bam-9817	89	6	infection	infection	NOUN
bam-9817	89	7	eur	eur	PROPN
bam-9817	89	8	j	j	PROPN
bam-9817	89	9	transl	transl	PROPN
bam-9817	89	10	myol	myol	ADV
bam-9817	89	11	31	31	NUM
bam-9817	89	12	(	(	PUNCT
bam-9817	89	13	3	3	NUM
bam-9817	89	14	):	):	PUNCT
bam-9817	89	15	9817	9817	NUM
bam-9817	89	16	,	,	PUNCT
bam-9817	89	17	2021	2021	NUM
bam-9817	89	18	doi	doi	NOUN
bam-9817	89	19	:	:	PUNCT
bam-9817	89	20	10.4081	10.4081	NUM
bam-9817	89	21	/	/	SYM
bam-9817	89	22	ejtm.2021.9817	ejtm.2021.9817	NOUN
bam-9817	89	23	4	4	NUM
bam-9817	89	24	prevalence	prevalence	NOUN
bam-9817	89	25	and	and	CCONJ
bam-9817	89	26	association	association	NOUN
bam-9817	89	27	with	with	ADP
bam-9817	89	28	clinical	clinical	ADJ
bam-9817	89	29	outcomes	outcome	NOUN
bam-9817	89	30	in	in	ADP
bam-9817	89	31	a	a	DET
bam-9817	89	32	large	large	ADJ
bam-9817	89	33	u.s	u.s	PROPN
bam-9817	89	34	.	.	PROPN
bam-9817	89	35	cohort	cohort	PROPN
bam-9817	89	36	.	.	PUNCT
bam-9817	90	1	hepatology	hepatology	NOUN
bam-9817	90	2	.	.	PUNCT
bam-9817	91	1	2020	2020	NUM
bam-9817	91	2	sep;72(3):807	sep;72(3):807	NOUN
bam-9817	91	3	-	-	SYM
bam-9817	91	4	817	817	NUM
bam-9817	91	5	.	.	PUNCT
bam-9817	92	1	doi	doi	NOUN
bam-9817	92	2	:	:	PUNCT
bam-9817	92	3	10.1002	10.1002	NUM
bam-9817	92	4	/	/	SYM
bam-9817	92	5	hep.31404	hep.31404	NOUN
bam-9817	92	6	.	.	NOUN
bam-9817	93	1	6	6	NUM
bam-9817	93	2	.	.	X
bam-9817	93	3	sun	sun	PROPN
bam-9817	93	4	j	j	PROPN
bam-9817	93	5	,	,	PUNCT
bam-9817	93	6	aghemo	aghemo	VERB
bam-9817	93	7	a	a	PRON
bam-9817	93	8	,	,	PUNCT
bam-9817	93	9	forner	forner	NOUN
bam-9817	93	10	a	a	NOUN
bam-9817	93	11	,	,	PUNCT
bam-9817	93	12	valenti	valenti	PROPN
bam-9817	93	13	l.	l.	PROPN
bam-9817	93	14	covid-19	covid-19	PROPN
bam-9817	93	15	and	and	CCONJ
bam-9817	93	16	liver	liver	NOUN
bam-9817	93	17	disease	disease	NOUN
bam-9817	93	18	.	.	PUNCT
bam-9817	94	1	liver	liver	NOUN
bam-9817	94	2	int	int	NOUN
bam-9817	94	3	.	.	PUNCT
bam-9817	95	1	2020	2020	NUM
bam-9817	96	1	jun;40(6):12781281	jun;40(6):12781281	PROPN
bam-9817	96	2	.	.	PUNCT
bam-9817	96	3	doi	doi	PROPN
bam-9817	96	4	:	:	PUNCT
bam-9817	96	5	10.1111	10.1111	NUM
bam-9817	96	6	/	/	SYM
bam-9817	96	7	liv.14470	liv.14470	NOUN
bam-9817	96	8	.	.	PUNCT
bam-9817	97	1	7	7	X
bam-9817	97	2	.	.	X
bam-9817	97	3	bernal	bernal	PROPN
bam-9817	97	4	w	w	PROPN
bam-9817	97	5	,	,	PUNCT
bam-9817	97	6	wendon	wendon	PROPN
bam-9817	97	7	j.	j.	PROPN
bam-9817	97	8	acute	acute	PROPN
bam-9817	97	9	liver	liver	NOUN
bam-9817	97	10	failure	failure	NOUN
bam-9817	97	11	.	.	PUNCT
bam-9817	98	1	n	n	CCONJ
bam-9817	98	2	engl	engl	PROPN
bam-9817	98	3	j	j	PROPN
bam-9817	98	4	med	med	PROPN
bam-9817	98	5	.	.	PUNCT
bam-9817	99	1	2013	2013	NUM
bam-9817	99	2	dec	dec	PROPN
bam-9817	99	3	26;369(26):2525	26;369(26):2525	PROPN
bam-9817	99	4	-	-	SYM
bam-9817	99	5	34	34	NUM
bam-9817	99	6	.	.	PUNCT
bam-9817	99	7	doi	doi	NOUN
bam-9817	99	8	:	:	PUNCT
bam-9817	99	9	10.1056	10.1056	NUM
bam-9817	99	10	/	/	SYM
bam-9817	99	11	nejmra1208937	nejmra1208937	PROPN
bam-9817	99	12	.	.	PUNCT
bam-9817	100	1	submitted	submit	VERB
bam-9817	100	2	:	:	PUNCT
bam-9817	100	3	april	april	PROPN
bam-9817	100	4	18	18	NUM
bam-9817	100	5	,	,	PUNCT
bam-9817	100	6	2021	2021	NUM
bam-9817	100	7	revision	revision	NOUN
bam-9817	100	8	received	receive	VERB
bam-9817	100	9	:	:	PUNCT
bam-9817	100	10	may	may	AUX
bam-9817	100	11	18	18	NUM
bam-9817	100	12	,	,	PUNCT
bam-9817	100	13	2021	2021	NUM
bam-9817	100	14	accepted	accept	VERB
bam-9817	100	15	for	for	ADP
bam-9817	100	16	publication	publication	NOUN
bam-9817	100	17	:	:	PUNCT
bam-9817	100	18	may	may	AUX
bam-9817	100	19	22	22	NUM
bam-9817	100	20	,	,	PUNCT
bam-9817	100	21	2021	2021	NUM